{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/mp5b00209.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": "error", "content": "<p>Cerebral\namyloid angiopathy (CAA) is a disorder affecting the elderly\nthat is characterized by amyloid-\u03b2 (A\u03b2) deposition in\nblood vessel walls of the brain. A series of <sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>-labeled benzothiazole derivatives as potential SPECT imaging\nprobes for cerebrovascular A\u03b2 deposition is reported. Rhenium\nsurrogate displayed high affinities to A\u03b2 aggregates with <italic toggle=\"yes\">K</italic>\n<sub>i</sub> values ranging from 106 to 42 nM, and they\nstrongly stained A\u03b2 deposits in transgenic mice (Tg) and Alzheimer\u2019s\ndisease (AD) patients. In vitro autoradiography on brain sections\nof Tg and AD patients confirmed that [<sup>99m</sup>Tc]<bold>24</bold> possessed sufficient affinity for A\u03b2 plaques, and [<sup>99m</sup>Tc]<bold>24</bold> could only label A\u03b2 deposition in blood\nvessels but not A\u03b2 plaques in the parenchyma of the brain of\nAD patients. Moreover, [<sup>99m</sup>Tc]<bold>24</bold> possessed\nfavorable initial uptake (1.21% ID/g) and fast blood washout (blood<sub>2 min</sub>/blood<sub>60 min</sub> = 23) in normal mice. These preliminary\nresults suggest that [<sup>99m</sup>Tc]<bold>24</bold> may be used\nas an A\u03b2 imaging probe for the detection of CAA.</p>", "clean_text": "Cerebral amyloid angiopathy (CAA) is a disorder affecting the elderly that is characterized by amyloid-\u03b2 (A\u03b2) deposition in blood vessel walls of the brain. A series of 99mTc(CO)3-labeled benzothiazole derivatives as potential SPECT imaging probes for cerebrovascular A\u03b2 deposition is reported. Rhenium surrogate displayed high affinities to A\u03b2 aggregates with K i values ranging from 106 to 42 nM, and they strongly stained A\u03b2 deposits in transgenic mice (Tg) and Alzheimer's disease (AD) patients. In vitro autoradiography on brain sections of Tg and AD patients confirmed that [99mTc]24 possessed sufficient affinity for A\u03b2 plaques, and [99mTc]24 could only label A\u03b2 deposition in blood vessels but not A\u03b2 plaques in the parenchyma of the brain of AD patients. Moreover, [99mTc]24 possessed favorable initial uptake (1.21% ID/g) and fast blood washout (blood2 min/blood60 min = 23) in normal mice. These preliminary results suggest that [99mTc]24 may be used as an A\u03b2 imaging probe for the detection of CAA.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>Cerebral\namyloid angiopathy (CAA) is a progressive degenerative\ndisease characterized by A\u03b2 deposition in the walls of leptomeningeal,\ncortical small- or middle-sized arteries, capillaries, and veins of\nthe brain, and it always results in the rupture and dysfunction of\ncerebral vessels. The abnormal accumulation of A\u03b2\nprotein leads to the formation of neuritic plaques in the brain, which\nis also one of the distinct pathological hallmarks of Alzheimer\u2019s\ndisease (AD). Neuropathological studies\nsuggest that A\u03b2 deposits in blood vessel walls and the brain\nparenchyma can proceed simultaneously or separately, resulting in\nobvious biological overlaps between CAA and AD. Although the\nrelationship between these two diseases remains unclear, subtle differences\nexist between the vascular amyloid deposition in CAA and the parenchymal\namyloid deposition in AD. For example, A\u03b2<sub>1\u201340</sub> is more abundant in the cerebrovascular amyloid of CAA, whereas\nA\u03b2<sub>1\u201342</sub> tends to be the primary form observed\nin the parenchymal plaques of AD. Based on the\npathological detection, CAA is a fairly common clinical entity, present\nin approximately 10% to 40% of elderly individuals. More than 90%\nof AD patients have histological evidence that A\u03b2 also deposits\nwithin cerebral vessels because these two diseases share a common\npathogenesis. However, postmortal histopathological assessment\nis the only method to enable the definitive identification of CAA.\nIn the clinic, elderly people with spontaneous intracerebral hemorrhage\n(ICH) are always considered candidates for CAA diagnosis. However,\nthe diagnostic reliance on cerebral hemorrhage as a surrogate marker\nfor CAA has several limitations preventing the early detection of\nCAA. Therefore, the development of a\nnoninvasive imaging method for accurate diagnosis and quantification\nof CAA would be highly significant.</p>", "clean_text": "Introduction\n\nCerebral amyloid angiopathy (CAA) is a progressive degenerative disease characterized by A\u03b2 deposition in the walls of leptomeningeal, cortical small- or middle-sized arteries, capillaries, and veins of the brain, and it always results in the rupture and dysfunction of cerebral vessels. The abnormal accumulation of A\u03b2 protein leads to the formation of neuritic plaques in the brain, which is also one of the distinct pathological hallmarks of Alzheimer's disease (AD). Neuropathological studies suggest that A\u03b2 deposits in blood vessel walls and the brain parenchyma can proceed simultaneously or separately, resulting in obvious biological overlaps between CAA and AD. Although the relationship between these two diseases remains unclear, subtle differences exist between the vascular amyloid deposition in CAA and the parenchymal amyloid deposition in AD. For example, A\u03b21-40 is more abundant in the cerebrovascular amyloid of CAA, whereas A\u03b21-42 tends to be the primary form observed in the parenchymal plaques of AD. Based on the pathological detection, CAA is a fairly common clinical entity, present in approximately 10% to 40% of elderly individuals. More than 90% of AD patients have histological evidence that A\u03b2 also deposits within cerebral vessels because these two diseases share a common pathogenesis. However, postmortal histopathological assessment is the only method to enable the definitive identification of CAA. In the clinic, elderly people with spontaneous intracerebral hemorrhage (ICH) are always considered candidates for CAA diagnosis. However, the diagnostic reliance on cerebral hemorrhage as a surrogate marker for CAA has several limitations preventing the early detection of CAA. Therefore, the development of a noninvasive imaging method for accurate diagnosis and quantification of CAA would be highly significant.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<p>A\u03b2 deposition, as\na common pathological hallmark of both\nAD and CAA, is a target for imaging agents. Research on A\u03b2 imaging\nagents for the diagnosis of AD in humans has achieved significant\nprogress in past decades. [<sup>18</sup>F]\u00adAV-45 (florbetapir/AMYVID), [<sup>18</sup>F]\u00adGE067 (flutemetamol/VIZAMYL), and [<sup>18</sup>F]\u00adBAY-94-9172 (florbetaben/NEURACEQ) have been approved by the U.S. Food and Drug Administration as clinical\nradiopharmaceuticals for the diagnosis of AD. [<sup>11</sup>C]\u00adPIB,\nthe most used A\u03b2 imaging agent, has been reported for detection\nof CAA. However, [<sup>11</sup>C]\u00adPIB could penetrate the\nBBB efficiently and was unable to distinguish A\u03b2 deposits between\nwithin blood vessels and in cerebral parenchyma accurately. Similarly, other A\u03b2 imaging agents designed\nfor AD are unable to specifically diagnose and quantify CAA due to\ntheir limited selectivity for A\u03b2 deposition in different regions.\nThus far, limited research has been performed on the development of\nimaging agents for specific diagnosis of CAA. Kung et al. reported\nthe \u201cbivalent or trivalent ligands\u201d containing two or\nthree styrylpyridine binding cores as specific CAA imaging agents\nbased on the reduction of brain uptake. According to this principle, reported herein is the design and biological\nevaluation of a series of negatively charged imaging probes with limited\nBBB penetration for the selective detection of vascular A\u03b2 deposition.\nBenzothiazole scaffold as the binding moiety is connected to a <sup>99m</sup>Tc-chelating moiety via different length of carbon chains.\nThe common chelation ligand iminodiacetic acid (IDA), which can form\nnegatively charged compounds with the [<sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>(H<sub>2</sub>O)<sub>3</sub>]<sup>+</sup> core, was easily introduced\n(Figure ).</p>", "clean_text": "A\u03b2 deposition, as a common pathological hallmark of both AD and CAA, is a target for imaging agents. Research on A\u03b2 imaging agents for the diagnosis of AD in humans has achieved significant progress in past decades. [18F]AV-45 (florbetapir/AMYVID), [18F]GE067 (flutemetamol/VIZAMYL), and [18F]BAY-94-9172 (florbetaben/NEURACEQ) have been approved by the U.S. Food and Drug Administration as clinical radiopharmaceuticals for the diagnosis of AD. [11C]PIB, the most used A\u03b2 imaging agent, has been reported for detection of CAA. However, [11C]PIB could penetrate the BBB efficiently and was unable to distinguish A\u03b2 deposits between within blood vessels and in cerebral parenchyma accurately. Similarly, other A\u03b2 imaging agents designed for AD are unable to specifically diagnose and quantify CAA due to their limited selectivity for A\u03b2 deposition in different regions. Thus far, limited research has been performed on the development of imaging agents for specific diagnosis of CAA. Kung et al. reported the \"bivalent or trivalent ligands\" containing two or three styrylpyridine binding cores as specific CAA imaging agents based on the reduction of brain uptake. According to this principle, reported herein is the design and biological evaluation of a series of negatively charged imaging probes with limited BBB penetration for the selective detection of vascular A\u03b2 deposition. Benzothiazole scaffold as the binding moiety is connected to a 99mTc-chelating moiety via different length of carbon chains. The common chelation ligand iminodiacetic acid (IDA), which can form negatively charged compounds with the [99mTc(CO)3(H2O)3]+ core, was easily introduced (Figure ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Chemical structure of A\u03b2 imaging\nprobes for CAA. <sup>18</sup>F-Polypegylated styrylpyridines (reported\npreviously) and <sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>-benzothiazoles (reported\nin the present study).</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"mp-2015-00209m_0011.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 1  Chemical structure of A\u03b2 imaging probes for CAA. 18F-Polypegylated styrylpyridines (reported previously) and 99mTc(CO)3-benzothiazoles (reported in the present study).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<title>Materials and Methods</title><title>General Information</title><p>All reagents\nused in the synthesis\nwere commercial products and were used without further purification\nunless otherwise indicated. The <sup>99m</sup>Tc-pertechnetate was\neluted from a commercial <sup>99</sup>Mo/<sup>99m</sup>Tc generator\nwhich was obtained from Beijing Atomic High-Tech Co. The <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were obtained at 400 MHz on\nBruker Avance III NMR spectrometers in CDCl<sub>3</sub>, DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub> or CD<sub>3</sub>OD solutions at room temperature\nwith TMS as an internal standard. Mass spectra were acquired using\na SurveyorMSQ Plus (ESI) (Waltham, MA, USA) instrument. Reactions\nwere monitored by TLC (silica gel 60 F254 aluminum sheets, Merck),\nand compounds were visualized by illumination with a short wavelength\nUV lamp (\u03bb = 254 or 365 nm). Column chromatographic purification\nwas performed on a silica gel (54\u201374 \u03bcm) from Qingdao\nHaiyang Chemical Co., Ltd. X-ray crystallography data were collected\non a Bruker Smart APEX II diffractometer (Bruker, Germany). Transgenic\nmice (C57BL6, APPswe/PSEN1, 12 or 23 months old, female) used as AD\nmodel and normal mice (C57BL6, 12 or 23 months old, female) were purchased\nfrom the Institute of Laboratory Animal Science, Chinese Academy of\nMedical Sciences. Postmortem brain tissues from autopsy-confirmed\ncases of AD patients (64 years old, female, temporal lobe; 68 years\nold, female, frontal lobe), a CAA patient (70 years old, male, temporal\nlobe), and a control subject (79 years old, male, temporal lobe) were\nobtained from the Chinese Brain Bank Center. All protocols requiring\nthe use of animals were approved by the animal care committee of Beijing\nNormal University.</p>", "clean_text": "Materials and Methods\n\nGeneral Information\n\nAll reagents used in the synthesis were commercial products and were used without further purification unless otherwise indicated. The 99mTc-pertechnetate was eluted from a commercial 99Mo/99mTc generator which was obtained from Beijing Atomic High-Tech Co. The 1H NMR and 13C NMR spectra were obtained at 400 MHz on Bruker Avance III NMR spectrometers in CDCl3, DMSO-d 6 or CD3OD solutions at room temperature with TMS as an internal standard. Mass spectra were acquired using a SurveyorMSQ Plus (ESI) (Waltham, MA, USA) instrument. Reactions were monitored by TLC (silica gel 60 F254 aluminum sheets, Merck), and compounds were visualized by illumination with a short wavelength UV lamp (\u03bb = 254 or 365 nm). Column chromatographic purification was performed on a silica gel (54-74 \u03bcm) from Qingdao Haiyang Chemical Co., Ltd. X-ray crystallography data were collected on a Bruker Smart APEX II diffractometer (Bruker, Germany). Transgenic mice (C57BL6, APPswe/PSEN1, 12 or 23 months old, female) used as AD model and normal mice (C57BL6, 12 or 23 months old, female) were purchased from the Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences. Postmortem brain tissues from autopsy-confirmed cases of AD patients (64 years old, female, temporal lobe; 68 years old, female, frontal lobe), a CAA patient (70 years old, male, temporal lobe), and a control subject (79 years old, male, temporal lobe) were obtained from the Chinese Brain Bank Center. All protocols requiring the use of animals were approved by the animal care committee of Beijing Normal University.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis</title><title>Synthesis of Compounds <bold>1</bold>\u2013<bold>8</bold>\n</title><p>A mixture of 2-(4-(methylamino)\u00adphenyl)\u00adbenzo\u00ad[<italic toggle=\"yes\">d</italic>]\u00adthiazol-6-ol\n(256.9 mg, 1.0 mmol) and K<sub>2</sub>CO<sub>3</sub> (429.9 mg, 3.1\nmmol) in CH<sub>3</sub>CN (30 mL) was stirred at 90 \u00b0C. After\n2 h, 1,3-dibromopropane (404.6 mg, 4.0 mmol) was added and the reaction\nmixture was kept at 90 \u00b0C for an additional 2 h. Then, K<sub>2</sub>CO<sub>3</sub> was filtered and CH<sub>3</sub>CN was removed\nunder vacuum. The residue was suspended in petroleum, and the product\nwas precipitated and filtered without further purification. Compounds <bold>2</bold>\u2013<bold>8</bold> were obtained by the same method as\ndescribed above. The yields and <sup>1</sup>H NMR data are shown in\nthe .</p>", "clean_text": "Synthesis\n\nSynthesis of Compounds 1-8 \n\nA mixture of 2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol (256.9 mg, 1.0 mmol) and K2CO3 (429.9 mg, 3.1 mmol) in CH3CN (30 mL) was stirred at 90 \u00b0C. After 2 h, 1,3-dibromopropane (404.6 mg, 4.0 mmol) was added and the reaction mixture was kept at 90 \u00b0C for an additional 2 h. Then, K2CO3 was filtered and CH3CN was removed under vacuum. The residue was suspended in petroleum, and the product was precipitated and filtered without further purification. Compounds 2-8 were obtained by the same method as described above. The yields and 1H NMR data are shown in the .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 7, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis\nof Compounds <bold>9</bold>\u2013<bold>16</bold>\n</title><p>A mixture\nof diethyl iminodiacetate (178.2 mg, 0.98 mmol), <bold>1</bold> (247.3\nmg, 0.65 mmol), K<sub>2</sub>CO<sub>3</sub> (268.7\nmg, 1.95 mmol), and KI (107.7 mg, 0.65 mmol) in CH<sub>3</sub>CN (10\nmL) was heated to reflux for 48 h at 90 \u00b0C. After CH<sub>3</sub>CN was removed, water was added, the resulting mixture was extracted\nby dichloromethane (3 \u00d7 20 mL), and the organic layer was dried\nover anhydrous MgSO<sub>4</sub>. The organic solvent was removed under\nvacuum, and the residue was purified by silica gel column chromatography\n(petroleum ether/AcOEt, 2/1) to yield 79.7 mg of <bold>9</bold> as\na light yellow solid. Compounds <bold>10</bold>\u2013<bold>16</bold> were obtained by the same method as described above. The yields\nand <sup>1</sup>H NMR and MS data are shown in the .</p>", "clean_text": "Synthesis of Compounds 9-16 \n\nA mixture of diethyl iminodiacetate (178.2 mg, 0.98 mmol), 1 (247.3 mg, 0.65 mmol), K2CO3 (268.7 mg, 1.95 mmol), and KI (107.7 mg, 0.65 mmol) in CH3CN (10 mL) was heated to reflux for 48 h at 90 \u00b0C. After CH3CN was removed, water was added, the resulting mixture was extracted by dichloromethane (3 \u00d7 20 mL), and the organic layer was dried over anhydrous MgSO4. The organic solvent was removed under vacuum, and the residue was purified by silica gel column chromatography (petroleum ether/AcOEt, 2/1) to yield 79.7 mg of 9 as a light yellow solid. Compounds 10-16 were obtained by the same method as described above. The yields and 1H NMR and MS data are shown in the .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 8, "type": "text", "classification": ["else"], "content": "<title>Synthesis of Compounds <bold>17</bold>\u2013<bold>24</bold>\n</title><p>Compound <bold>9</bold> (79.7 mg, 0.16 mmol) was dissolved\nin MeOH (2 mL), and then 2 M NaOH solution was added (1 mL). The solution\nwas refluxed for 2 h until compound <bold>9</bold> was completely\nhydrolyzed. Then, the pH value of the solution was adjusted to 8 by\nadding a few drops of hydrochloric acid (2 M), the mixture was refluxed\nfor an additional 30 min, and then Re\u00ad(CO)<sub>5</sub>Cl (56.7 mg,\n0.16 mmol) was added and the mixture was refluxed for another 2 h.\nAfter removal of the MeOH, water was added, and the resulting precipitate\nwas washed with ethyl acetate to obtain 89.6 mg of <bold>17</bold> as a deep yellow solid. Compounds <bold>18</bold>\u2013<bold>24</bold> were obtained by the same method as described above. The yields\nand <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS data are shown\nin the .</p>", "clean_text": "Synthesis of Compounds 17-24 \n\nCompound 9 (79.7 mg, 0.16 mmol) was dissolved in MeOH (2 mL), and then 2 M NaOH solution was added (1 mL). The solution was refluxed for 2 h until compound 9 was completely hydrolyzed. Then, the pH value of the solution was adjusted to 8 by adding a few drops of hydrochloric acid (2 M), the mixture was refluxed for an additional 30 min, and then Re(CO)5Cl (56.7 mg, 0.16 mmol) was added and the mixture was refluxed for another 2 h. After removal of the MeOH, water was added, and the resulting precipitate was washed with ethyl acetate to obtain 89.6 mg of 17 as a deep yellow solid. Compounds 18-24 were obtained by the same method as described above. The yields and 1H NMR, 13C NMR, and HRMS data are shown in the .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 9, "type": "text", "classification": ["else"], "content": "<title>X-ray Crystallography</title><p>Compound <bold>24</bold> could\nbe recrystallized by the slow evaporation of a mixed <italic toggle=\"yes\">n</italic>-hexane and CH<sub>2</sub>Cl<sub>2</sub> solution to obtain X-ray\nquality crystals. Single-crystal X-ray diffraction measurements were\nperformed on a Bruker Smart APEXII CCD diffractometer at 100 K using\ngraphite monochromated M\u03bf K\u03b1 radiation (\u03bb = 0.71073\n\u00c5). The structures were solved by direct methods and refined\nby full-matrix least-squares on <italic toggle=\"yes\">F</italic>\n<sup>2</sup> using\nthe SHELXL-97 program package.\n</p>", "clean_text": "X-ray Crystallography\n\nCompound 24 could be recrystallized by the slow evaporation of a mixed n-hexane and CH2Cl2 solution to obtain X-ray quality crystals. Single-crystal X-ray diffraction measurements were performed on a Bruker Smart APEXII CCD diffractometer at 100 K using graphite monochromated M\u03bf K\u03b1 radiation (\u03bb = 0.71073 \u00c5). The structures were solved by direct methods and refined by full-matrix least-squares on F 2 using the SHELXL-97 program package. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 10, "type": "text", "classification": ["else"], "content": "<title>Radiolabeling</title><p>To solutions of compounds <bold>9</bold>\u2013<bold>16</bold> in\nEtOH (2 mL) was added 1 mL of NaOH solution\n(2 M). These mixtures were refluxed for 1 h until the hydrolysis was\ncomplete. Then, the pH value of these solutions was adjusted to 2\nby adding a few drops of concentrated hydrochloric acid, and after\nfiltration, the carboxylic compounds were obtained as yellow solids.\nA freshly prepared solution (1 mL) of the <italic toggle=\"yes\">fac-</italic>[<sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>(H<sub>2</sub>O)<sub>3</sub>]<sup>+</sup> intermediate (pH = 7) was added to a vial containing carboxylic\nprecursors (0.5 mg) in EtOH (200 \u03bcL). The vial was sealed and\nheated for 20 min at 90 \u00b0C. After cooling to room temperature,\nthe resulting mixture was purified by HPLC (Shimadzu SCL-20 AVP, SPD-20A\nUV detector, and Bioscan Flow Count 3200 NaI/PMT \u03b3-radiation\nscintillation detector). Conditions for HPLC purification were as\nfollows: Venusil MP C18 reverse phase column (Agela Technologies,\n5 \u03bcm, 4.6 mm \u00d7 250 mm), CH<sub>3</sub>CN/H<sub>2</sub>O\n= 55/45 (0.1% of TFA) for [<sup>99m</sup>Tc]<bold>17</bold>, [<sup>99m</sup>Tc]<bold>18</bold>, [<sup>99m</sup>Tc]<bold>19</bold>, [<sup>99m</sup>Tc]<bold>21</bold>, and [<sup>99m</sup>Tc]<bold>22</bold>; CH<sub>3</sub>CN/H<sub>2</sub>O = 50/50 (0.1% of TFA) for [<sup>99m</sup>Tc]<bold>20</bold>, [<sup>99m</sup>Tc]<bold>23</bold>, and\n[<sup>99m</sup>Tc]<bold>24</bold>, 1 mL/min. Then, the collected fractions\nwere neutralized by adding NaHCO<sub>3</sub> powder. The identities\nof these <sup>99m</sup>Tc-labeled tracers were confirmed by coinjection\nand coelution with the corresponding rhenium complexes under the following\nconditions: Venusil MP C18 reverse phase column (Agela Technologies,\n5 \u03bcm, 4.6 mm \u00d7 250 mm), CH<sub>3</sub>CN/H<sub>2</sub>O\n= 50/50 (0.1% of TFA) for all tracers.</p>", "clean_text": "Radiolabeling\n\nTo solutions of compounds 9-16 in EtOH (2 mL) was added 1 mL of NaOH solution (2 M). These mixtures were refluxed for 1 h until the hydrolysis was complete. Then, the pH value of these solutions was adjusted to 2 by adding a few drops of concentrated hydrochloric acid, and after filtration, the carboxylic compounds were obtained as yellow solids. A freshly prepared solution (1 mL) of the fac-[99mTc(CO)3(H2O)3]+ intermediate (pH = 7) was added to a vial containing carboxylic precursors (0.5 mg) in EtOH (200 \u03bcL). The vial was sealed and heated for 20 min at 90 \u00b0C. After cooling to room temperature, the resulting mixture was purified by HPLC (Shimadzu SCL-20 AVP, SPD-20A UV detector, and Bioscan Flow Count 3200 NaI/PMT \u03b3-radiation scintillation detector). Conditions for HPLC purification were as follows: Venusil MP C18 reverse phase column (Agela Technologies, 5 \u03bcm, 4.6 mm \u00d7 250 mm), CH3CN/H2O = 55/45 (0.1% of TFA) for [99mTc]17, [99mTc]18, [99mTc]19, [99mTc]21, and [99mTc]22; CH3CN/H2O = 50/50 (0.1% of TFA) for [99mTc]20, [99mTc]23, and [99mTc]24, 1 mL/min. Then, the collected fractions were neutralized by adding NaHCO3 powder. The identities of these 99mTc-labeled tracers were confirmed by coinjection and coelution with the corresponding rhenium complexes under the following conditions: Venusil MP C18 reverse phase column (Agela Technologies, 5 \u03bcm, 4.6 mm \u00d7 250 mm), CH3CN/H2O = 50/50 (0.1% of TFA) for all tracers.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 11, "type": "text", "classification": ["else"], "content": "<title>Partition Coefficient Determination</title><p>The partition coefficients\nof <sup>99m</sup>Tc-labeled complexes were determined using a previously\nreported procedure.\n</p><title>Tissue Staining</title><p>Paraffin-embedded brain sections from\nmice and humans were pretreated according to previously reported methods. Brain sections were incubated with 10% EtOH\nsolutions (1.0 \u03bcM) of <bold>17</bold>\u2013<bold>24</bold> for 10 min at room temperature, and the adjacent sections were stained\nwith thioflavin-S (0.125%). Finally, all sections were washed with\n40% EtOH for 5 min. Triple staining was performed using complex <bold>24</bold> (1.0 \u03bcM in 10% EtOH solution), <bold>2c</bold> (1.0\n\u03bcM in 10% EtOH solution, a near-infrared fluorescence (NIRF)\nprobe for A\u03b2), and FITC phalloidin\n(100 nM in PBS containing 1% BSA and 10% MeOH, a vascular smooth muscle\ncell (VSMC) marker) on the same fresh frozen brain section from Tg\nmice or wild-type mice. Fluorescent images were obtained using an\nAxio Observer Z1 (Zeiss, Germany) equipped with DAPI, GFP, and Texas\nRed filter sets.</p>", "clean_text": "Partition Coefficient Determination\n\nThe partition coefficients of 99mTc-labeled complexes were determined using a previously reported procedure. \n\nTissue Staining\n\nParaffin-embedded brain sections from mice and humans were pretreated according to previously reported methods. Brain sections were incubated with 10% EtOH solutions (1.0 \u03bcM) of 17-24 for 10 min at room temperature, and the adjacent sections were stained with thioflavin-S (0.125%). Finally, all sections were washed with 40% EtOH for 5 min. Triple staining was performed using complex 24 (1.0 \u03bcM in 10% EtOH solution), 2c (1.0 \u03bcM in 10% EtOH solution, a near-infrared fluorescence (NIRF) probe for A\u03b2), and FITC phalloidin (100 nM in PBS containing 1% BSA and 10% MeOH, a vascular smooth muscle cell (VSMC) marker) on the same fresh frozen brain section from Tg mice or wild-type mice. Fluorescent images were obtained using an Axio Observer Z1 (Zeiss, Germany) equipped with DAPI, GFP, and Texas Red filter sets.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 12, "type": "text", "classification": ["else"], "content": "<title>In Vitro Binding Inhibition Assays Using\nA\u03b2 Aggregates</title><p>In vitro inhibition assay experiments\nwere performed as described\npreviously with some modifications. A\nmixture was prepared by combining 100 \u03bcL of A\u03b2 aggregated\nfibrils (aggregated A\u03b2<sub>1\u201342</sub> peptide, prepared\nas reported previously, 28 nM in the final assay mixture), 100 \u03bcL\nof radioligand ([<sup>125</sup>I]\u00adIMPY, 100000 cpm/100 \u03bcL), 100\n\u03bcL of inhibitors (complexes <bold>17</bold>\u2013<bold>24</bold>, 10<sup>\u20134</sup> M to 10<sup>\u20139.5</sup> M in EtOH),\n100 \u03bcL of DMSO, and 600 \u03bcL of BSA (0.1%, pH = 7.4) with\na final volume of 1.0 mL in borosilicate glass tubes (12 mm \u00d7\n75 mm). Other steps were the same as described in the literature.\nFor complex <bold>24</bold>, an in vitro inhibition assay using A\u03b2<sub>1\u201340</sub> aggregates was also performed using the same method.\nThe binding and blocking assays were performed as previously described\nwith some modifications. In these assays,\n100 \u03bcL of A\u03b2<sub>1\u201340</sub> aggregates or A\u03b2<sub>1\u201342</sub> aggregates (7.27 \u03bcg/mL) was added to borosilicate\nglass tubes (12 mm \u00d7 75 mm) containing 100 \u03bcL of [<sup>99m</sup>Tc]<bold>24</bold> (3 \u00d7 10<sup>6</sup> cpm/100 \u03bcL)\nand 800 \u03bcL of 10% EtOH. The blocking assay was carried out in\nthe same way as the binding assay, but in the presence of an excess\nof rhenium complexes <bold>24</bold> (0.5 \u03bcM) as blocking agents.\nThe mixture was incubated for 2 h at room temperature and then filtered\nwith an Mp-48T cell harvester (Brandel, Gaithersburg, MD) using Whatman\nGF/B filters. The bound [<sup>99m</sup>Tc]<bold>24</bold> on filters\nwas detected using an automatic \u03b3-counter (Wallac 1470 Wizard,\nUSA).</p>", "clean_text": "In Vitro Binding Inhibition Assays Using A\u03b2 Aggregates\n\nIn vitro inhibition assay experiments were performed as described previously with some modifications. A mixture was prepared by combining 100 \u03bcL of A\u03b2 aggregated fibrils (aggregated A\u03b21-42 peptide, prepared as reported previously, 28 nM in the final assay mixture), 100 \u03bcL of radioligand ([125I]IMPY, 100000 cpm/100 \u03bcL), 100 \u03bcL of inhibitors (complexes 17-24, 10-4 M to 10-9.5 M in EtOH), 100 \u03bcL of DMSO, and 600 \u03bcL of BSA (0.1%, pH = 7.4) with a final volume of 1.0 mL in borosilicate glass tubes (12 mm \u00d7 75 mm). Other steps were the same as described in the literature. For complex 24, an in vitro inhibition assay using A\u03b21-40 aggregates was also performed using the same method. The binding and blocking assays were performed as previously described with some modifications. In these assays, 100 \u03bcL of A\u03b21-40 aggregates or A\u03b21-42 aggregates (7.27 \u03bcg/mL) was added to borosilicate glass tubes (12 mm \u00d7 75 mm) containing 100 \u03bcL of [99mTc]24 (3 \u00d7 106 cpm/100 \u03bcL) and 800 \u03bcL of 10% EtOH. The blocking assay was carried out in the same way as the binding assay, but in the presence of an excess of rhenium complexes 24 (0.5 \u03bcM) as blocking agents. The mixture was incubated for 2 h at room temperature and then filtered with an Mp-48T cell harvester (Brandel, Gaithersburg, MD) using Whatman GF/B filters. The bound [99mTc]24 on filters was detected using an automatic \u03b3-counter (Wallac 1470 Wizard, USA).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 13, "type": "text", "classification": ["else"], "content": "<title>Autoradiography Studies</title><p>For in vitro autoradiography\nstudies, the pretreated brain sections of mice and human were incubated\nwith [<sup>99m</sup>Tc]<bold>24</bold> (1.85 \u00d7 10<sup>10</sup> Bq/L) or [<sup>125</sup>I]\u00adIMPY (7.40 \u00d7 10<sup>9</sup> Bq/L)\nin 10% EtOH for 1 h at room temperature. The sections were then washed\nwith 40% EtOH. After drying, the sections were exposed to a phosphorus\nplate (PerkinElmer, USA) for 60 min. The images were obtained using\na phosphor imaging system (Cyclone, Packard). Finally, the same brain\nsections were stained by thioflavin-S. Ex vivo studies were carried\nout using Tg mice (23 months old) and age-matched case. A saline solution\n(10% EtOH) of [<sup>99m</sup>Tc]<bold>24</bold> (37 MBq) was injected\ninto the tail vein. After 30 min, the mice were sacrificed by decapitation\nand the brains were removed and frozen at \u221230 \u00b0C. Then,\nsections with thicknesses of 20 \u03bcm were cut and exposed to a\nphosphorus plate for 10 h. The ex vivo autoradiograms were obtained\nas described above. Similarly, the same sections were stained using\nthioflavin-S to confirm the presence of A\u03b2 deposits on blood\nvessel walls and in the brain parenchyma.</p>", "clean_text": "Autoradiography Studies\n\nFor in vitro autoradiography studies, the pretreated brain sections of mice and human were incubated with [99mTc]24 (1.85 \u00d7 1010 Bq/L) or [125I]IMPY (7.40 \u00d7 109 Bq/L) in 10% EtOH for 1 h at room temperature. The sections were then washed with 40% EtOH. After drying, the sections were exposed to a phosphorus plate (PerkinElmer, USA) for 60 min. The images were obtained using a phosphor imaging system (Cyclone, Packard). Finally, the same brain sections were stained by thioflavin-S. Ex vivo studies were carried out using Tg mice (23 months old) and age-matched case. A saline solution (10% EtOH) of [99mTc]24 (37 MBq) was injected into the tail vein. After 30 min, the mice were sacrificed by decapitation and the brains were removed and frozen at -30 \u00b0C. Then, sections with thicknesses of 20 \u03bcm were cut and exposed to a phosphorus plate for 10 h. The ex vivo autoradiograms were obtained as described above. Similarly, the same sections were stained using thioflavin-S to confirm the presence of A\u03b2 deposits on blood vessel walls and in the brain parenchyma.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 14, "type": "text", "classification": "error", "content": "<title>Biodistribution Studies</title><p>A group of normal mice (ICR,\n5 weeks, male, <italic toggle=\"yes\">n</italic> = 5) were used for each time point\n(2, 10, 30, and 60 min) of the biodistribution studies. The mice were\ninjected with 100 \u03bcL of saline solution (10% EtOH) containing\n185 kBq of tracers via the lateral tail vein. The mice were sacrificed\nexactly at the above time points. The organs of interest were weighed,\nand the radioactivity was measured with a \u03b3-counter. Finally,\nthe percentage of the injected dose per gram (% ID/g) of blood or\ntissue was calculated (the results for some organs were expressed\nas % ID/organ).</p>", "clean_text": "Biodistribution Studies\n\nA group of normal mice (ICR, 5 weeks, male, n = 5) were used for each time point (2, 10, 30, and 60 min) of the biodistribution studies. The mice were injected with 100 \u03bcL of saline solution (10% EtOH) containing 185 kBq of tracers via the lateral tail vein. The mice were sacrificed exactly at the above time points. The organs of interest were weighed, and the radioactivity was measured with a \u03b3-counter. Finally, the percentage of the injected dose per gram (% ID/g) of blood or tissue was calculated (the results for some organs were expressed as % ID/organ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 15, "type": "text", "classification": ["else"], "content": "<title>Results</title><title>Synthesis and Radiolabeling</title><p>Rhenium complexes as surrogates\nof <sup>99m</sup>Tc complexes were successfully synthesized and fully\ncharacterized (Scheme ). 6-Hydroxybenzothiazole\nderivatives prepared as reported previously were reacted with dibromoalkane compounds using K<sub>2</sub>CO<sub>3</sub> as a base in CH<sub>3</sub>CN to form a bromo-aliphatic intermediate\nwith chemical yields ranging from 26.7% to 79.8%. Then, the bromo-aliphatic\ncompounds <bold>1</bold>\u2013<bold>8</bold> were conjugated with\nIDA chelating ligand in CH<sub>3</sub>CN with K<sub>2</sub>CO<sub>3</sub> as the base and KI as the catalyst to generate precursors <bold>9</bold>\u2013<bold>16</bold> with chemical yields ranging from\n21.1% to 62.5%. The precursors were further hydrolyzed using NaOH\nas the base in methanol, and then the corresponding rhenium complexes <bold>17</bold>\u2013<bold>24</bold> were achieved by reacting the hydrolyzed\nprecursors with Re\u00ad(CO)<sub>5</sub>Cl under alkaline conditions (pH\n= 8). Complex <bold>24</bold> could be recrystallized by the slow\nevaporation of a mixed <italic toggle=\"yes\">n</italic>-hexane and CH<sub>2</sub>Cl<sub>2</sub> solution to obtain X-ray quality crystals. The ORTEP\nstructure of <bold>24</bold> is displayed in Figure , and relevant crystallographic data are provided in Table\nS1 in the . The crystal\nexists in the form of a sodium salt with two crystal waters; specifically,\none carbonyl oxygen atom of the IDA ligand is coordinated with a sodium\natom, which is coordinated with two oxygen atoms from two water molecules.\nThe coordination geometry about rhenium is a distorted octahedron\nconsisting of the <italic toggle=\"yes\">fac</italic>-[Re\u00ad(CO)<sub>3</sub>]<sup>+</sup> moiety and a set of tridentate NOO ligands composed of a tertiary\namine nitrogen and two carboxylated oxygen atoms.</p>", "clean_text": "Results\n\nSynthesis and Radiolabeling\n\nRhenium complexes as surrogates of 99mTc complexes were successfully synthesized and fully characterized (Scheme ). 6-Hydroxybenzothiazole derivatives prepared as reported previously were reacted with dibromoalkane compounds using K2CO3 as a base in CH3CN to form a bromo-aliphatic intermediate with chemical yields ranging from 26.7% to 79.8%. Then, the bromo-aliphatic compounds 1-8 were conjugated with IDA chelating ligand in CH3CN with K2CO3 as the base and KI as the catalyst to generate precursors 9-16 with chemical yields ranging from 21.1% to 62.5%. The precursors were further hydrolyzed using NaOH as the base in methanol, and then the corresponding rhenium complexes 17-24 were achieved by reacting the hydrolyzed precursors with Re(CO)5Cl under alkaline conditions (pH = 8). Complex 24 could be recrystallized by the slow evaporation of a mixed n-hexane and CH2Cl2 solution to obtain X-ray quality crystals. The ORTEP structure of 24 is displayed in Figure , and relevant crystallographic data are provided in Table S1 in the . The crystal exists in the form of a sodium salt with two crystal waters; specifically, one carbonyl oxygen atom of the IDA ligand is coordinated with a sodium atom, which is coordinated with two oxygen atoms from two water molecules. The coordination geometry about rhenium is a distorted octahedron consisting of the fac-[Re(CO)3]+ moiety and a set of tridentate NOO ligands composed of a tertiary amine nitrogen and two carboxylated oxygen atoms.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 16, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Synthesis of Rhenium\nComplexes<xref ref-type=\"fn\" rid=\"sch1-fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"mp-2015-00209m_0007.tif\" xlink:type=\"simple\"></graphic>\n<p>\n<fn id=\"sch1-fn1\">\n<label>a</label>\n<p>Reagents and conditions: (a)\nK<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 90 \u00b0C, 4 h; (b)\ndiethyl iminodiacetate, K<sub>2</sub>CO<sub>3</sub>, KI, CH<sub>3</sub>CN, 90 \u00b0C, 2\u20133 d; (c) (1) 2 M NaOH, CH<sub>3</sub>OH,\n70 \u00b0C, 1 h; (2) HCl, pH = 8, 30 min; (3) Re\u00ad(CO)<sub>5</sub>Cl,\n2 h.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 1  Synthesis of Rhenium Complexes      a Reagents and conditions: (a) K2CO3, CH3CN, 90 \u00b0C, 4 h; (b) diethyl iminodiacetate, K2CO3, KI, CH3CN, 90 \u00b0C, 2-3 d; (c) (1) 2 M NaOH, CH3OH, 70 \u00b0C, 1 h; (2) HCl, pH = 8, 30 min; (3) Re(CO)5Cl, 2 h.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 17, "type": "text", "classification": ["else"], "content": "<p>\n<fn id=\"sch1-fn1\">\n<label>a</label>\n<p>Reagents and conditions: (a)\nK<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 90 \u00b0C, 4 h; (b)\ndiethyl iminodiacetate, K<sub>2</sub>CO<sub>3</sub>, KI, CH<sub>3</sub>CN, 90 \u00b0C, 2\u20133 d; (c) (1) 2 M NaOH, CH<sub>3</sub>OH,\n70 \u00b0C, 1 h; (2) HCl, pH = 8, 30 min; (3) Re\u00ad(CO)<sub>5</sub>Cl,\n2 h.</p>\n</fn>\n</p>", "clean_text": "  a Reagents and conditions: (a) K2CO3, CH3CN, 90 \u00b0C, 4 h; (b) diethyl iminodiacetate, K2CO3, KI, CH3CN, 90 \u00b0C, 2-3 d; (c) (1) 2 M NaOH, CH3OH, 70 \u00b0C, 1 h; (2) HCl, pH = 8, 30 min; (3) Re(CO)5Cl, 2 h.  ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 18, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Crystal structure of complex <bold>24</bold> (thermal\nellipsoids\ndrawn at the 30% probability level).</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"mp-2015-00209m_0012.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 2  Crystal structure of complex 24 (thermal ellipsoids drawn at the 30% probability level).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 19, "type": "text", "classification": "error", "content": "<p>To prepare the <sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>-labeled benzothiazole\ncomplexes [<sup>99m</sup>Tc]<bold>17</bold>\u2013<bold>24</bold>, the intermediate <italic toggle=\"yes\">fac</italic>-[<sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>(H<sub>2</sub>O)<sub>3</sub>]<sup>+</sup> was first obtained\nas described previously. Then, the hydrolysates\nof <bold>9</bold>\u2013<bold>16</bold> were reacted with the intermediate\nto form crude <sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>-labeled products by\nligand exchange reactions (Scheme ). [<sup>99m</sup>Tc]<bold>17</bold>\u2013<bold>24</bold> were obtained\nwith high radiochemical yields (&gt;90%) and high radiochemical purity\n(&gt;95%) after purification. The radiotracers were identified by\ncomparing\nthe HPLC retention time with the corresponding rhenium complexes through\ncoinjection and coelution (Table S2 and Figure S1 in the ). In addition, the log <italic toggle=\"yes\">D</italic> values for [<sup>99m</sup>Tc]<bold>17</bold>\u2013<bold>24</bold> (2.72 \u00b1 0.15, 2.73 \u00b1 0.11, 2.99 \u00b1 0.31,\n3.12 \u00b1 0.36, 2.74 \u00b1 0.23, 2.39 \u00b1 0.05, 2.55 \u00b1\n0.11, and 3.03 \u00b1 0.07, respectively) demonstrate that these tracers\nare suitable for brain imaging.</p>", "clean_text": "To prepare the 99mTc(CO)3-labeled benzothiazole complexes [99mTc]17-24, the intermediate fac-[99mTc(CO)3(H2O)3]+ was first obtained as described previously. Then, the hydrolysates of 9-16 were reacted with the intermediate to form crude 99mTc(CO)3-labeled products by ligand exchange reactions (Scheme ). [99mTc]17-24 were obtained with high radiochemical yields (>90%) and high radiochemical purity (>95%) after purification. The radiotracers were identified by comparing the HPLC retention time with the corresponding rhenium complexes through coinjection and coelution (Table S2 and Figure S1 in the ). In addition, the log D values for [99mTc]17-24 (2.72 \u00b1 0.15, 2.73 \u00b1 0.11, 2.99 \u00b1 0.31, 3.12 \u00b1 0.36, 2.74 \u00b1 0.23, 2.39 \u00b1 0.05, 2.55 \u00b1 0.11, and 3.03 \u00b1 0.07, respectively) demonstrate that these tracers are suitable for brain imaging.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 20, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Synthesis of <sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>-Labeled Benzothiazole\nDerivatives<xref ref-type=\"fn\" rid=\"sch2-fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"mp-2015-00209m_0008.tif\" xlink:type=\"simple\"></graphic>\n<p>\n<fn id=\"sch2-fn1\">\n<label>a</label>\n<p>Reagents and conditions: (1)\n2 M NaOH, EtOH, 90 \u00b0C, 1 h; (2) HCl, pH = 2; (3) <italic toggle=\"yes\">fac</italic>-[<sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>(H<sub>2</sub>O)<sub>3</sub>]<sup>+</sup>, EtOH, 90 \u00b0C, 20 min, pH = 7.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 2  Synthesis of 99mTc(CO)3-Labeled Benzothiazole Derivatives      a Reagents and conditions: (1) 2 M NaOH, EtOH, 90 \u00b0C, 1 h; (2) HCl, pH = 2; (3) fac-[99mTc(CO)3(H2O)3]+, EtOH, 90 \u00b0C, 20 min, pH = 7.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 21, "type": "text", "classification": ["else"], "content": "<p>\n<fn id=\"sch2-fn1\">\n<label>a</label>\n<p>Reagents and conditions: (1)\n2 M NaOH, EtOH, 90 \u00b0C, 1 h; (2) HCl, pH = 2; (3) <italic toggle=\"yes\">fac</italic>-[<sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>(H<sub>2</sub>O)<sub>3</sub>]<sup>+</sup>, EtOH, 90 \u00b0C, 20 min, pH = 7.</p>\n</fn>\n</p><title>Tissue\nStaining</title><p>Staining of the brain section from\nTg mice with complex <bold>24</bold> resulted in unambiguous and specific\nlabeling of A\u03b2 plaques in the cerebral parenchyma (Figure A) and blood vessels (Figure D); the results were in agreement with the thioflavin-S staining\npattern of the adjacent section (Figure B)\nor costaining on the same sections using a NIRF probe <bold>2c</bold>. Furthermore, intense labeling of A\u03b2 deposits within the blood\nvessels and in the cerebral parenchyma with low background was also\nobserved on brain sections of AD patient for complex <bold>24</bold> (Figure C,G). In contrast, no apparent labeling\nwas observed in the brain section of normal mice and normal human\n(Figure S2 in the ). Similarly, good staining results were observed in the brain sections\nof Tg mice for complexes <bold>17</bold>\u2013<bold>23</bold> as\nshown in Figure S3 in the . To explore whether <bold>24-</bold>positive A\u03b2 deposition\ninfluenced the structure of blood vessels, triple staining was performed\nusing complex <bold>24</bold>, <bold>2c</bold>, and a VSMC marker\nFITC phalloidin on the fresh frozen brain sections from aged wild-type\nmice and Tg mice. As shown in Figure , VSMCs\nwere arranged closely in parallel in wild-type mice, and the vessels\ndid not stain with complex <bold>24</bold> and <bold>2c</bold>. In\ncontrast, complex <bold>24</bold> and <bold>2c</bold> clearly labeled\nA\u03b2 deposits in cerebral vessels of aged Tg mice, and VSMC arrangement\nwas substantially disrupted in these vessels, which is a characteristic\nfeature of CAA.</p>", "clean_text": "  a Reagents and conditions: (1) 2 M NaOH, EtOH, 90 \u00b0C, 1 h; (2) HCl, pH = 2; (3) fac-[99mTc(CO)3(H2O)3]+, EtOH, 90 \u00b0C, 20 min, pH = 7.  \n\nTissue Staining\n\nStaining of the brain section from Tg mice with complex 24 resulted in unambiguous and specific labeling of A\u03b2 plaques in the cerebral parenchyma (Figure A) and blood vessels (Figure D); the results were in agreement with the thioflavin-S staining pattern of the adjacent section (Figure B) or costaining on the same sections using a NIRF probe 2c. Furthermore, intense labeling of A\u03b2 deposits within the blood vessels and in the cerebral parenchyma with low background was also observed on brain sections of AD patient for complex 24 (Figure C,G). In contrast, no apparent labeling was observed in the brain section of normal mice and normal human (Figure S2 in the ). Similarly, good staining results were observed in the brain sections of Tg mice for complexes 17-23 as shown in Figure S3 in the . To explore whether 24-positive A\u03b2 deposition influenced the structure of blood vessels, triple staining was performed using complex 24, 2c, and a VSMC marker FITC phalloidin on the fresh frozen brain sections from aged wild-type mice and Tg mice. As shown in Figure , VSMCs were arranged closely in parallel in wild-type mice, and the vessels did not stain with complex 24 and 2c. In contrast, complex 24 and 2c clearly labeled A\u03b2 deposits in cerebral vessels of aged Tg mice, and VSMC arrangement was substantially disrupted in these vessels, which is a characteristic feature of CAA.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 22, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>In vitro fluorescent staining of complex <bold>24</bold> (DAPI\nfilter) on paraffin-embedded brain section from Tg mice (C57BL6, APPswe/PSEN1,\n12 months old, female) (A) and AD patient (64 years old, female, temporal\nlobe) (C); the adjacent brain sections from Tg mice were stained by\nthioflavin-S (B, GFP filter). Higher magnification of blood vessels\non brain section of Tg mice (D\u2013F) and AD patient (68 years\nold, female, frontal lobe) (G\u2013I) costained by complex <bold>24</bold> (D and G, DAPI filter) and a near-infrared fluorescence\ndye <bold>2c</bold> (E and H, Texas Red filter). The A\u03b2 plaques\nin cerebral parenchyma are indicated by arrows; A\u03b2 deposits\nin blood vessels are indicated by triangles. Complex <bold>24</bold> binds A\u03b2 deposits both in cerebral parenchyma and blood vessels.</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"float\" xlink:href=\"mp-2015-00209m_0001.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 3  In vitro fluorescent staining of complex 24 (DAPI filter) on paraffin-embedded brain section from Tg mice (C57BL6, APPswe/PSEN1, 12 months old, female) (A) and AD patient (64 years old, female, temporal lobe) (C); the adjacent brain sections from Tg mice were stained by thioflavin-S (B, GFP filter). Higher magnification of blood vessels on brain section of Tg mice (D-F) and AD patient (68 years old, female, frontal lobe) (G-I) costained by complex 24 (D and G, DAPI filter) and a near-infrared fluorescence dye 2c (E and H, Texas Red filter). The A\u03b2 plaques in cerebral parenchyma are indicated by arrows; A\u03b2 deposits in blood vessels are indicated by triangles. Complex 24 binds A\u03b2 deposits both in cerebral parenchyma and blood vessels.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 23, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>In vitro triple fluorescent staining of complex <bold>24</bold> (blue, DAPI filter), a vascular smooth muscle cell (VSMC)\nmarker\nFITC phalloidin (green, GFP filter), and a near-infrared fluorescence\ndye <bold>2c</bold> (red, Texas Red filter) on fresh frozen brain\nsection from wild-type mice (C57BL6, 23 months old, female) (A\u2013D)\nand Tg mice (C57BL6, APPswe/PSEN1, 23 months old, female) (E\u2013H).\nComplex <bold>24</bold> and <bold>2c</bold> staining was absent in\nage-matched wild-type mice, and VSMCs were arranged closely in parallel.\nIn contrast, they stained A\u03b2 deposits in cerebral vessels of\naged Tg mice and VSMC arrangement was substantially disrupted in the\nvessels.</p>\n</caption>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"float\" xlink:href=\"mp-2015-00209m_0002.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 4  In vitro triple fluorescent staining of complex 24 (blue, DAPI filter), a vascular smooth muscle cell (VSMC) marker FITC phalloidin (green, GFP filter), and a near-infrared fluorescence dye 2c (red, Texas Red filter) on fresh frozen brain section from wild-type mice (C57BL6, 23 months old, female) (A-D) and Tg mice (C57BL6, APPswe/PSEN1, 23 months old, female) (E-H). Complex 24 and 2c staining was absent in age-matched wild-type mice, and VSMCs were arranged closely in parallel. In contrast, they stained A\u03b2 deposits in cerebral vessels of aged Tg mice and VSMC arrangement was substantially disrupted in the vessels.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 24, "type": "text", "classification": "error", "content": "<title>In Vitro Binding Assays</title><p>Rhenium complexes <bold>17</bold>\u2013<bold>24</bold> exhibited\nmoderate affinities to A\u03b2<sub>1\u201342</sub> aggregates with <italic toggle=\"yes\">K</italic>\n<sub>i</sub> values\nranging from 106 to 42 nM (Table  and Figure\nS4B in the ). For\ncomplex <bold>24</bold>, the affinity for A\u03b2<sub>1\u201340</sub> aggregates is slightly stronger than for A\u03b2<sub>1\u201342</sub> aggregates (IC<sub>50</sub> = 37.0 \u00b1 10.3 and 64.5 \u00b1 7.8,\nrespectively) (Figure S4A in the ). Furthermore, the direct binding potential of [<sup>99m</sup>Tc]<bold>24</bold> to A\u03b2<sub>1\u201340</sub> and A\u03b2<sub>1\u201342</sub> aggregates is shown in Figure ; the A\u03b2<sub>1\u201340</sub> aggregate-bound radioactivity (%) was slightly\nhigher than that of A\u03b2<sub>1\u201342</sub> aggregates (10.15%\nvs 6.48%), while the intermediate [<sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>(H<sub>2</sub>O)<sub>3</sub>]<sup>+</sup> displayed no remarkable\nbinding to A\u03b2<sub>1\u201340</sub> or A\u03b2<sub>1\u201342</sub> aggregates. The binding of [<sup>99m</sup>Tc]<bold>24</bold> to\nboth A\u03b2<sub>1\u201340</sub> and A\u03b2<sub>1\u201342</sub> aggregates could be blocked by over 80% (87.1% and 81.5%, respectively)\nby an excess of rhenium complex <bold>24</bold> (0.5 \u03bcM).</p>", "clean_text": "In Vitro Binding Assays\n\nRhenium complexes 17-24 exhibited moderate affinities to A\u03b21-42 aggregates with K i values ranging from 106 to 42 nM (Table  and Figure S4B in the ). For complex 24, the affinity for A\u03b21-40 aggregates is slightly stronger than for A\u03b21-42 aggregates (IC50 = 37.0 \u00b1 10.3 and 64.5 \u00b1 7.8, respectively) (Figure S4A in the ). Furthermore, the direct binding potential of [99mTc]24 to A\u03b21-40 and A\u03b21-42 aggregates is shown in Figure ; the A\u03b21-40 aggregate-bound radioactivity (%) was slightly higher than that of A\u03b21-42 aggregates (10.15% vs 6.48%), while the intermediate [99mTc(CO)3(H2O)3]+ displayed no remarkable binding to A\u03b21-40 or A\u03b21-42 aggregates. The binding of [99mTc]24 to both A\u03b21-40 and A\u03b21-42 aggregates could be blocked by over 80% (87.1% and 81.5%, respectively) by an excess of rhenium complex 24 (0.5 \u03bcM).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 25, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Inhibition Constants (<italic toggle=\"yes\">K</italic>\n<sub>i</sub>, nM) for Binding to Aggregates of A\u03b2<sub>1\u201342</sub>\n<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">compound</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">K</italic>\n<sub>i</sub>\n</oasis:entry>\n<oasis:entry align=\"center\">compound</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">K</italic>\n<sub>i</sub>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>17</bold>\n</oasis:entry>\n<oasis:entry>106.0\u00a0\u00b1\u00a029.9</oasis:entry>\n<oasis:entry>\n<bold>21</bold>\n</oasis:entry>\n<oasis:entry>85.1\u00a0\u00b1\u00a011.2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>18</bold>\n</oasis:entry>\n<oasis:entry>45.3\u00a0\u00b1\u00a011.8</oasis:entry>\n<oasis:entry>\n<bold>22</bold>\n</oasis:entry>\n<oasis:entry>50.8\u00a0\u00b1\u00a012.5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>19</bold>\n</oasis:entry>\n<oasis:entry>46.0\u00a0\u00b1\u00a012.0</oasis:entry>\n<oasis:entry>\n<bold>23</bold>\n</oasis:entry>\n<oasis:entry>56.6\u00a0\u00b1\u00a04.1</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>20</bold>\n</oasis:entry>\n<oasis:entry>61.9\u00a0\u00b1\u00a08.4</oasis:entry>\n<oasis:entry>\n<bold>24</bold>\n</oasis:entry>\n<oasis:entry>42.2\u00a0\u00b1\u00a011.3</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>Measured in triplicate,\nwith results\nreported as the mean \u00b1 SD.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<p>Binding\nassay of [<sup>99m</sup>Tc]<bold>24</bold> with A\u03b2<sub>1\u201340</sub> and A\u03b2<sub>1\u201342</sub> aggregates in\nthe presence or absence of <bold>24</bold> as a blocker. Reported\nvalues are the mean \u00b1 SD (<italic toggle=\"yes\">n</italic> = 3). Student\u2019s <italic toggle=\"yes\">t</italic> test (independent, two-tailed) was performed, <italic toggle=\"yes\">p</italic> &lt; 0.01.</p>\n</caption>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"float\" xlink:href=\"mp-2015-00209m_0003.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 5  Binding assay of [99mTc]24 with A\u03b21-40 and A\u03b21-42 aggregates in the presence or absence of 24 as a blocker. Reported values are the mean \u00b1 SD (n = 3). Student's t test (independent, two-tailed) was performed, p < 0.01.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 27, "type": "text", "classification": ["else"], "content": "<title>Autoradiography Studies</title><p>To investigate the binding\nability of [<sup>99m</sup>Tc]<bold>24</bold> to A\u03b2 plaques at\ntracer dose, in vitro autoradiography studies were first carried out\non brain sections of Tg mice and age-matched wild-type mice. As shown\nin Figure , [<sup>99m</sup>Tc]<bold>24</bold> exhibited excellent labeling of A\u03b2 deposits within blood vessels\nand cerebral parenchyma in the cortical and cerebellar regions of\nTg mouse brain, but this labeling was not observed in the wild-type\ncase (Figure S5 in the ). The selective binding ability of [<sup>99m</sup>Tc]<bold>24</bold> was further examined using brain sections of AD patients. Interestingly,\n[<sup>99m</sup>Tc]<bold>24</bold> was found to strongly bind to CAA-laden\ncerebral arterioles, but not to parenchymal plaques in brain sections\nof AD human. In contrast, [<sup>125</sup>I]\u00adIMPY, a common A\u03b2\nbinding agent, labeled A\u03b2 deposits in both cerebral arterioles\nand the parenchyma on congeneric brain section of AD human in in vitro\nautoradiography studies (Figure ). The similar\nin vitro autoradiography results were repeated on brain sections from\ndifferent patients (Figures S6 and S7 in the ). To further confirm that [<sup>99m</sup>Tc]<bold>24</bold> has the potential to selectively recognize A\u03b2 deposits\nlocated in cerebral arterioles, ex vivo autoradiography studies were\nperformed in Tg mice and wild-type mice. As shown in Figure , autoradiographic imaging revealed the presence\nof many radioactive spots on the brain section of the Tg mouse but\nno remarkable radioactive spots on the normal mouse brain section,\nand the radioactive spots were found to concentrate at the site of\nthe blood vessels in the Tg brain tissue as identified by in vitro\nfluorescence staining using thioflavin-S.</p>", "clean_text": "Autoradiography Studies\n\nTo investigate the binding ability of [99mTc]24 to A\u03b2 plaques at tracer dose, in vitro autoradiography studies were first carried out on brain sections of Tg mice and age-matched wild-type mice. As shown in Figure , [99mTc]24 exhibited excellent labeling of A\u03b2 deposits within blood vessels and cerebral parenchyma in the cortical and cerebellar regions of Tg mouse brain, but this labeling was not observed in the wild-type case (Figure S5 in the ). The selective binding ability of [99mTc]24 was further examined using brain sections of AD patients. Interestingly, [99mTc]24 was found to strongly bind to CAA-laden cerebral arterioles, but not to parenchymal plaques in brain sections of AD human. In contrast, [125I]IMPY, a common A\u03b2 binding agent, labeled A\u03b2 deposits in both cerebral arterioles and the parenchyma on congeneric brain section of AD human in in vitro autoradiography studies (Figure ). The similar in vitro autoradiography results were repeated on brain sections from different patients (Figures S6 and S7 in the ). To further confirm that [99mTc]24 has the potential to selectively recognize A\u03b2 deposits located in cerebral arterioles, ex vivo autoradiography studies were performed in Tg mice and wild-type mice. As shown in Figure , autoradiographic imaging revealed the presence of many radioactive spots on the brain section of the Tg mouse but no remarkable radioactive spots on the normal mouse brain section, and the radioactive spots were found to concentrate at the site of the blood vessels in the Tg brain tissue as identified by in vitro fluorescence staining using thioflavin-S.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 28, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig6\" orientation=\"portrait\" position=\"float\">\n<label>6</label>\n<caption>\n<p>In vitro autoradiography\nof [<sup>99m</sup>Tc]<bold>24</bold> binding\nin brain section from Tg mice (C57BL6, APPswe/PSEN1, 12 months old,\nfemale), and the right-hand side is a higher magnification image of\nthe area indicated by the square in the left-hand image (A). The presence\nand distribution of A\u03b2 plaques in cerebral parenchyma (arrows)\nand A\u03b2 deposits within the blood vessels (triangles) were confirmed\nby staining the same brain section with thioflavin-S (GFP filter)\n(B). [<sup>99m</sup>Tc]<bold>24</bold> binds both A\u03b2 plaques\nin cerebral parenchyma (arrows) and A\u03b2 deposits within the blood\nvessels (triangles) on Tg brain section.</p>\n</caption>\n<graphic id=\"gr8\" orientation=\"portrait\" position=\"float\" xlink:href=\"mp-2015-00209m_0004.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 6  In vitro autoradiography of [99mTc]24 binding in brain section from Tg mice (C57BL6, APPswe/PSEN1, 12 months old, female), and the right-hand side is a higher magnification image of the area indicated by the square in the left-hand image (A). The presence and distribution of A\u03b2 plaques in cerebral parenchyma (arrows) and A\u03b2 deposits within the blood vessels (triangles) were confirmed by staining the same brain section with thioflavin-S (GFP filter) (B). [99mTc]24 binds both A\u03b2 plaques in cerebral parenchyma (arrows) and A\u03b2 deposits within the blood vessels (triangles) on Tg brain section.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 29, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig7\" orientation=\"portrait\" position=\"float\">\n<label>7</label>\n<caption>\n<p>In vitro autoradiography of [<sup>99m</sup>Tc]<bold>24</bold> on\ntwo adjacent brain sections of an AD patient (64 years old, female,\ntemporal lobe) and [<sup>125</sup>I]\u00adIMPY on the congeneric brain section.\nHigher magnification images show that A\u03b2 deposits within the\nblood vessels were clearly labeled by [<sup>99m</sup>Tc]<bold>24</bold> as indicated by the triangles, but A\u03b2 plaques in cerebral\nparenchyma were poorly labeled as indicated by the arrows. In contrast,\nthe both A\u03b2 were labeled by [<sup>125</sup>I]\u00adIMPY (A). Fluorescent\nstaining using thioflavin-S (GFP filter) on the same brain sections\nto confirm the distribution of A\u03b2, which correspond to the higher\nmagnification images in A (B). [<sup>99m</sup>Tc]<bold>24</bold> selectively\nbinds A\u03b2 deposits within the blood vessels (triangles) but not\nin cerebral parenchyma (arrows) on brain sections of AD patient, whereas\n[<sup>125</sup>I]\u00adIMPY labels both.</p>\n</caption>\n<graphic id=\"gr9\" orientation=\"portrait\" position=\"float\" xlink:href=\"mp-2015-00209m_0005.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 7  In vitro autoradiography of [99mTc]24 on two adjacent brain sections of an AD patient (64 years old, female, temporal lobe) and [125I]IMPY on the congeneric brain section. Higher magnification images show that A\u03b2 deposits within the blood vessels were clearly labeled by [99mTc]24 as indicated by the triangles, but A\u03b2 plaques in cerebral parenchyma were poorly labeled as indicated by the arrows. In contrast, the both A\u03b2 were labeled by [125I]IMPY (A). Fluorescent staining using thioflavin-S (GFP filter) on the same brain sections to confirm the distribution of A\u03b2, which correspond to the higher magnification images in A (B). [99mTc]24 selectively binds A\u03b2 deposits within the blood vessels (triangles) but not in cerebral parenchyma (arrows) on brain sections of AD patient, whereas [125I]IMPY labels both.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 30, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig8\" orientation=\"portrait\" position=\"float\">\n<label>8</label>\n<caption>\n<p>Ex vivo autoradiography of [<sup>99m</sup>Tc]<bold>24</bold> on\nthe brain section of a Tg mouse (C57BL6, APPswe/PSEN1, 23 months old,\nfemale) (A) and a wild-type control mouse (C57BL6, 23 months old,\nfemale) (B). Fluorescence staining using thioflavin-S (GFP filter)\non the same brain sections to confirm the presence of A\u03b2 plaques\n(C and D). Detail with enlarged scale of C, corresponding to the square\nareas of A; A\u03b2 deposits within the blood vessels (triangles)\nwere clearly labeled by [<sup>99m</sup>Tc]<bold>24</bold>, but A\u03b2\nplaques in cerebral parenchyma (arrows) were not marked (E). Detail\nwith enlarged scale of D, corresponding to the square areas of B (F).\n[<sup>99m</sup>Tc]<bold>24</bold> selectively binds A\u03b2 deposits\nwithin blood vessels (triangles) but not in cerebral parenchyma (arrows)\nin vivo.</p>\n</caption>\n<graphic id=\"gr10\" orientation=\"portrait\" position=\"float\" xlink:href=\"mp-2015-00209m_0006.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 8  Ex vivo autoradiography of [99mTc]24 on the brain section of a Tg mouse (C57BL6, APPswe/PSEN1, 23 months old, female) (A) and a wild-type control mouse (C57BL6, 23 months old, female) (B). Fluorescence staining using thioflavin-S (GFP filter) on the same brain sections to confirm the presence of A\u03b2 plaques (C and D). Detail with enlarged scale of C, corresponding to the square areas of A; A\u03b2 deposits within the blood vessels (triangles) were clearly labeled by [99mTc]24, but A\u03b2 plaques in cerebral parenchyma (arrows) were not marked (E). Detail with enlarged scale of D, corresponding to the square areas of B (F). [99mTc]24 selectively binds A\u03b2 deposits within blood vessels (triangles) but not in cerebral parenchyma (arrows) in vivo.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 31, "type": "text", "classification": ["property"], "content": "<title>Biodistribution Studies</title><p>The time\u2013radioactivity\ndata on brain penetration and the distribution of [<sup>99m</sup>Tc]<bold>24</bold> in other organs are displayed in Table . The results show a relatively low brain uptake of 1.21 \u00b1\n0.22% ID/g at 2 min postinjection and rapid blood washout with an\napproximately 23-fold decline in blood radioactivity at 60 min postinjection.\nOther complexes, [<sup>99m</sup>Tc]<bold>21</bold>, [<sup>99m</sup>Tc]<bold>22</bold>, and [<sup>99m</sup>Tc]<bold>23</bold> showed\nlower brain uptake (0.80 \u00b1 0.17, 0.61 \u00b1 0.08, and 0.88 \u00b1\n0.14% ID/g, respectively, in Table S3 in the ). These tracers are similar to most imaging agents\nin that they are metabolized by the liver and intestine. [<sup>99m</sup>Tc]<bold>24</bold> also exhibits remarkable stability in vitro and\nin vivo. As shown in Figure S8 in the , [<sup>99m</sup>Tc]<bold>24</bold> exists in the\nblood almost completely in its parent form after 30 min postinjection,\nand more than 50% is present in the urine at that time.</p>", "clean_text": "Biodistribution Studies\n\nThe time-radioactivity data on brain penetration and the distribution of [99mTc]24 in other organs are displayed in Table . The results show a relatively low brain uptake of 1.21 \u00b1 0.22% ID/g at 2 min postinjection and rapid blood washout with an approximately 23-fold decline in blood radioactivity at 60 min postinjection. Other complexes, [99mTc]21, [99mTc]22, and [99mTc]23 showed lower brain uptake (0.80 \u00b1 0.17, 0.61 \u00b1 0.08, and 0.88 \u00b1 0.14% ID/g, respectively, in Table S3 in the ). These tracers are similar to most imaging agents in that they are metabolized by the liver and intestine. [99mTc]24 also exhibits remarkable stability in vitro and in vivo. As shown in Figure S8 in the , [99mTc]24 exists in the blood almost completely in its parent form after 30 min postinjection, and more than 50% is present in the urine at that time.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 32, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Biodistribution in Normal Mice (ICR,\n5 Weeks, Male) after Iv Injection of [<sup>99m</sup>Tc]<bold>24</bold>\n<xref ref-type=\"table-fn\" rid=\"t2fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">organ</oasis:entry>\n<oasis:entry align=\"center\">2 min</oasis:entry>\n<oasis:entry align=\"center\">10 min</oasis:entry>\n<oasis:entry align=\"center\">30 min</oasis:entry>\n<oasis:entry align=\"center\">60 min</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>blood</oasis:entry>\n<oasis:entry>31.86\u00a0\u00b1\u00a03.19</oasis:entry>\n<oasis:entry>5.98\u00a0\u00b1\u00a00.78</oasis:entry>\n<oasis:entry>1.79\u00a0\u00b1\u00a00.24</oasis:entry>\n<oasis:entry>1.37\u00a0\u00b1\u00a00.14</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>brain</oasis:entry>\n<oasis:entry>1.21\u00a0\u00b1\u00a00.22</oasis:entry>\n<oasis:entry>0.19\u00a0\u00b1\u00a00.04</oasis:entry>\n<oasis:entry>0.07\u00a0\u00b1\u00a00.02</oasis:entry>\n<oasis:entry>0.06\u00a0\u00b1\u00a00.01</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>heart</oasis:entry>\n<oasis:entry>6.53\u00a0\u00b1\u00a00.79</oasis:entry>\n<oasis:entry>1.72\u00a0\u00b1\u00a00.15</oasis:entry>\n<oasis:entry>0.62\u00a0\u00b1\u00a00.07</oasis:entry>\n<oasis:entry>0.57\u00a0\u00b1\u00a00.14</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>liver</oasis:entry>\n<oasis:entry>25.64\u00a0\u00b1\u00a02.31</oasis:entry>\n<oasis:entry>34.65\u00a0\u00b1\u00a03.34</oasis:entry>\n<oasis:entry>21.79\u00a0\u00b1\u00a01.45</oasis:entry>\n<oasis:entry>11.01\u00a0\u00b1\u00a00.58</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>spleen</oasis:entry>\n<oasis:entry>3.36\u00a0\u00b1\u00a00.39</oasis:entry>\n<oasis:entry>1.06\u00a0\u00b1\u00a00.17</oasis:entry>\n<oasis:entry>0.49\u00a0\u00b1\u00a00.11</oasis:entry>\n<oasis:entry>0.38\u00a0\u00b1\u00a00.08</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>lung</oasis:entry>\n<oasis:entry>16.89\u00a0\u00b1\u00a02.13</oasis:entry>\n<oasis:entry>3.84\u00a0\u00b1\u00a00.73</oasis:entry>\n<oasis:entry>1.53\u00a0\u00b1\u00a00.08</oasis:entry>\n<oasis:entry>1.42\u00a0\u00b1\u00a00.22</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>kidney</oasis:entry>\n<oasis:entry>7.79\u00a0\u00b1\u00a00.84</oasis:entry>\n<oasis:entry>3.04\u00a0\u00b1\u00a00.53</oasis:entry>\n<oasis:entry>1.68\u00a0\u00b1\u00a00.20</oasis:entry>\n<oasis:entry>1.45\u00a0\u00b1\u00a00.15</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>pancreas</oasis:entry>\n<oasis:entry>1.63\u00a0\u00b1\u00a00.22</oasis:entry>\n<oasis:entry>1.20\u00a0\u00b1\u00a00.56</oasis:entry>\n<oasis:entry>0.55\u00a0\u00b1\u00a00.13</oasis:entry>\n<oasis:entry>0.34\u00a0\u00b1\u00a00.67</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>muscle</oasis:entry>\n<oasis:entry>0.77\u00a0\u00b1\u00a00.19</oasis:entry>\n<oasis:entry>0.76\u00a0\u00b1\u00a00.63</oasis:entry>\n<oasis:entry>0.26\u00a0\u00b1\u00a00.10</oasis:entry>\n<oasis:entry>0.28\u00a0\u00b1\u00a00.10</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>stomach<xref ref-type=\"table-fn\" rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry>0.77\u00a0\u00b1\u00a00.19</oasis:entry>\n<oasis:entry>0.76\u00a0\u00b1\u00a00.63</oasis:entry>\n<oasis:entry>0.26\u00a0\u00b1\u00a00.10</oasis:entry>\n<oasis:entry>0.28\u00a0\u00b1\u00a00.10</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>intestine<xref ref-type=\"table-fn\" rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry>1.67\u00a0\u00b1\u00a00.43</oasis:entry>\n<oasis:entry>13.65\u00a0\u00b1\u00a01.20</oasis:entry>\n<oasis:entry>47.57\u00a0\u00b1\u00a08.05</oasis:entry>\n<oasis:entry>28.34\u00a0\u00b1\u00a03.78</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>Expressed as %\ninjected dose per\ngram. Average for 5 mice \u00b1 SD.</p>\n</fn>\n<fn id=\"t2fn2\">\n<label>b</label>\n<p>Expressed as % injected dose per\norgan.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 33, "type": "text", "classification": "error", "content": "<title>Discussion</title><p>These\nresults suggest that [<sup>99m</sup>Tc]<bold>24</bold> may\nserve as promising candidate for SPECT imaging of CAA. The corresponding\nrhenium complex <bold>24</bold> with the longest carbon linker length\n(<italic toggle=\"yes\">n</italic> = 6) displayed the highest affinity toward A\u03b2<sub>1\u201342</sub> aggregates (<italic toggle=\"yes\">K</italic>\n<sub>i</sub> = 42.2\nnM) among the rhenium complexes with various lengths of carbon linkers\n(<italic toggle=\"yes\">n</italic> = 3\u20136); this result verified that the steric\nhindrance imposed by the bulky metal chelator on the binding motifs\nis alleviated by carbon linkers of appropriate length, leading to\nan increase in the binding affinity to A\u03b2 aggregates. Considering\nthat the A\u03b2<sub>1\u201340</sub> is more abundant in the cerebrovascular\namyloid of CAA, the imaging agent for CAA should have higher affinity\nfor A\u03b2<sub>1\u201340</sub> aggregates. In the inhibition binding\nand direct binding assay, rhenium complex <bold>24</bold> and [<sup>99m</sup>Tc]<bold>24</bold> both displayed better affinity to A\u03b2<sub>1\u201340</sub> than A\u03b2<sub>1\u201342</sub> aggregates,\nwhich may allow selective detection of A\u03b2 deposits associated\nwith CAA.</p>", "clean_text": "Discussion\n\nThese results suggest that [99mTc]24 may serve as promising candidate for SPECT imaging of CAA. The corresponding rhenium complex 24 with the longest carbon linker length (n = 6) displayed the highest affinity toward A\u03b21-42 aggregates (K i = 42.2 nM) among the rhenium complexes with various lengths of carbon linkers (n = 3-6); this result verified that the steric hindrance imposed by the bulky metal chelator on the binding motifs is alleviated by carbon linkers of appropriate length, leading to an increase in the binding affinity to A\u03b2 aggregates. Considering that the A\u03b21-40 is more abundant in the cerebrovascular amyloid of CAA, the imaging agent for CAA should have higher affinity for A\u03b21-40 aggregates. In the inhibition binding and direct binding assay, rhenium complex 24 and [99mTc]24 both displayed better affinity to A\u03b21-40 than A\u03b21-42 aggregates, which may allow selective detection of A\u03b2 deposits associated with CAA.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 34, "type": "text", "classification": ["else"], "content": "<p>The synthetic A\u03b2 fibers used in in vitro binding\nassay do\nnot correlate with the structure of A\u03b2 deposits in Tg mice and\nhuman brain. Thus, in vitro assays using brain samples are considered\nmore reliable. However, the autoradiography results with [<sup>99m</sup>Tc]<bold>24</bold> on human brains are different from the staining\nresults of the corresponding rhenium complex <bold>24</bold>, which\nstained A\u03b2 deposits within both the blood vessels and the cerebral\nparenchyma. This difference could be explained by the fact that rhenium\ncompound itself has different biological properties from the <sup>99m</sup>Tc-labeled complex, or it may result from the differences\nin concentration between [<sup>99m</sup>Tc]<bold>24</bold> and <bold>24</bold> applied in different experimental conditions. Previous\nreports showed that resorufin analogues could differentially detect\nA\u03b2 deposits based on their localization in cerebral vessels\nversus the brain parenchyma at low concentrations, but these agents\nwere nonselective at high concentrations. In the in vitro autoradiography experiment conducted here, the chemical\nconcentration of tracer [<sup>99m</sup>Tc]<bold>24</bold> (nanomolar\nrange) is significantly lower than that of rhenium complex <bold>24</bold> (micromolar range) used for the fluorescent staining experiment.</p>", "clean_text": "The synthetic A\u03b2 fibers used in in vitro binding assay do not correlate with the structure of A\u03b2 deposits in Tg mice and human brain. Thus, in vitro assays using brain samples are considered more reliable. However, the autoradiography results with [99mTc]24 on human brains are different from the staining results of the corresponding rhenium complex 24, which stained A\u03b2 deposits within both the blood vessels and the cerebral parenchyma. This difference could be explained by the fact that rhenium compound itself has different biological properties from the 99mTc-labeled complex, or it may result from the differences in concentration between [99mTc]24 and 24 applied in different experimental conditions. Previous reports showed that resorufin analogues could differentially detect A\u03b2 deposits based on their localization in cerebral vessels versus the brain parenchyma at low concentrations, but these agents were nonselective at high concentrations. In the in vitro autoradiography experiment conducted here, the chemical concentration of tracer [99mTc]24 (nanomolar range) is significantly lower than that of rhenium complex 24 (micromolar range) used for the fluorescent staining experiment.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 35, "type": "text", "classification": ["else"], "content": "<p>Many <sup>99m</sup>Tc-labeled tracers with sufficient affinities\ndisplayed intense labeling of A\u03b2 plaques in Tg mice but exhibited\nnegative results in AD human brain samples; interestingly, [<sup>99m</sup>Tc]<bold>24</bold> not only displayed\npositive autoradiography results but also selectively detected A\u03b2\nwithin the blood vessels on brain section of AD human. However, it\ndid not show such selectivity about the autoradiography results for\nthe brain sections from Tg mice. First, it may be due to differences\nin the configuration/folding of A\u03b2 plaques between human and\nmice. Second, the selectivity of [<sup>99m</sup>Tc]<bold>24</bold> to A\u03b2 deposits in cerebral arterioles\nin brain sections from AD patient may result from differences in the\ndegree of aggregation of the A\u03b2 peptide. In the selected brain\nsection from the AD patient, most of the plaques are diffuse, and\nthe neuritic plaques with higher degrees of aggregation are barely\nvisible, while the labeled plaques on the brain section of the aged\nTg mice are mostly neuritic plaques. In contrast, the deposits in\ncerebral arterioles are denser than the diffuse plaques, so [<sup>99m</sup>Tc]<bold>24</bold> may only detect the deposits in cerebral\narterioles due to their higher density. Another possibility is that\n[<sup>99m</sup>Tc]<bold>24</bold> preferentially detects aggregates\nof A\u03b2<sub>1\u201340</sub>, which is the major species of A\u03b2\nin CAA, while A\u03b2<sub>1\u201342</sub> predominates in parenchymal\nplaques. Actually, [<sup>99m</sup>Tc]<bold>24</bold> displayed better\naffinity to A\u03b2<sub>1\u201340</sub> than A\u03b2<sub>1\u201342</sub> aggregates in in vitro binding and blocking assays. In addition,\nthe result that [<sup>99m</sup>Tc]<bold>24</bold> specifically targeted\nonly vascular amyloid deposition in human tissue is similar to the\nspecific reactivity of a heavy chain antibody fragment (ni3A) for\nvascular A\u03b2 on human brain section.\n</p>", "clean_text": "Many 99mTc-labeled tracers with sufficient affinities displayed intense labeling of A\u03b2 plaques in Tg mice but exhibited negative results in AD human brain samples; interestingly, [99mTc]24 not only displayed positive autoradiography results but also selectively detected A\u03b2 within the blood vessels on brain section of AD human. However, it did not show such selectivity about the autoradiography results for the brain sections from Tg mice. First, it may be due to differences in the configuration/folding of A\u03b2 plaques between human and mice. Second, the selectivity of [99mTc]24 to A\u03b2 deposits in cerebral arterioles in brain sections from AD patient may result from differences in the degree of aggregation of the A\u03b2 peptide. In the selected brain section from the AD patient, most of the plaques are diffuse, and the neuritic plaques with higher degrees of aggregation are barely visible, while the labeled plaques on the brain section of the aged Tg mice are mostly neuritic plaques. In contrast, the deposits in cerebral arterioles are denser than the diffuse plaques, so [99mTc]24 may only detect the deposits in cerebral arterioles due to their higher density. Another possibility is that [99mTc]24 preferentially detects aggregates of A\u03b21-40, which is the major species of A\u03b2 in CAA, while A\u03b21-42 predominates in parenchymal plaques. Actually, [99mTc]24 displayed better affinity to A\u03b21-40 than A\u03b21-42 aggregates in in vitro binding and blocking assays. In addition, the result that [99mTc]24 specifically targeted only vascular amyloid deposition in human tissue is similar to the specific reactivity of a heavy chain antibody fragment (ni3A) for vascular A\u03b2 on human brain section. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 36, "type": "text", "classification": ["else"], "content": "<p>As very few reports have been published on imaging agents\nthat\nspecifically target CAA, the criteria for CAA imaging agents have\nnot been fully established, especially in terms of the degree of BBB\npenetration. Bacskai et al. reported that vascular amyloid deposits\nin Tg mouse were weakly labeled after iv injection of thioflavin-T,\nwhile the amyloid deposits in the parenchyma were not labeled. Thioflavin-T is not expected to efficiently\ncross the intact BBB due to its positive charge and low lipophilicity.\nLikewise, Kung and co-workers have reported multidentate styrylpyridine\nderivatives that selectively detect CAA due to low brain uptake. Based on these results, decreasing the initial\nbrain uptake may help to improve the selectivity of imaging agents\nto CAA. However, larger and hydrophilic molecule thioflavin-S failed\nto label either parenchymal A\u03b2 deposition or vascular amyloid\ndeposition when it was injected into a Tg mouse, and amyloid aggregates generally exist inside the blood\nvessels, especially in the early stage of CAA. Thus, imaging agents targeting amyloid aggregates in CAA\nshould have a certain ability to penetrate the BBB; the moderate initial\nbrain uptake of [<sup>99m</sup>Tc]<bold>24</bold> may be more promising.\nIn this study, the control of brain uptake is only one aspect with\nthe potential to enhance the selectivity, as [<sup>99m</sup>Tc]<bold>24</bold> itself is selective for vascular amyloid deposits according\nto the results from in vitro autoradiography studies on brain sections\nof AD patients. Moreover, the ex vivo autoradiography studies in Tg\nmice and wild-type further confirmed that [<sup>99m</sup>Tc]<bold>24</bold> has the potential to selectively recognize A\u03b2 deposits\nlocated in cerebral arterioles.</p>", "clean_text": "As very few reports have been published on imaging agents that specifically target CAA, the criteria for CAA imaging agents have not been fully established, especially in terms of the degree of BBB penetration. Bacskai et al. reported that vascular amyloid deposits in Tg mouse were weakly labeled after iv injection of thioflavin-T, while the amyloid deposits in the parenchyma were not labeled. Thioflavin-T is not expected to efficiently cross the intact BBB due to its positive charge and low lipophilicity. Likewise, Kung and co-workers have reported multidentate styrylpyridine derivatives that selectively detect CAA due to low brain uptake. Based on these results, decreasing the initial brain uptake may help to improve the selectivity of imaging agents to CAA. However, larger and hydrophilic molecule thioflavin-S failed to label either parenchymal A\u03b2 deposition or vascular amyloid deposition when it was injected into a Tg mouse, and amyloid aggregates generally exist inside the blood vessels, especially in the early stage of CAA. Thus, imaging agents targeting amyloid aggregates in CAA should have a certain ability to penetrate the BBB; the moderate initial brain uptake of [99mTc]24 may be more promising. In this study, the control of brain uptake is only one aspect with the potential to enhance the selectivity, as [99mTc]24 itself is selective for vascular amyloid deposits according to the results from in vitro autoradiography studies on brain sections of AD patients. Moreover, the ex vivo autoradiography studies in Tg mice and wild-type further confirmed that [99mTc]24 has the potential to selectively recognize A\u03b2 deposits located in cerebral arterioles.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 37, "type": "text", "classification": ["else"], "content": "<title>Conclusion</title><p>The\nresults of our preliminary study suggest that a <sup>99m</sup>Tc\u00ad(CO)<sub>3</sub>-labeled benzothiazole derivative, [<sup>99m</sup>Tc]<bold>24</bold>, exhibited sufficient affinity for A\u03b2 aggregates\nand could selectively label A\u03b2 deposits in blood vessels of\nAD brain sections. The specific binding of [<sup>99m</sup>Tc]<bold>24</bold> and its selectivity to A\u03b2 deposits in blood vessel\nwalls were validated by ex vivo autoradiographic experiments with\nTg mice. Further experimental data will be required to confirm the\nutility of [<sup>99m</sup>Tc]<bold>24</bold> as novel imaging agent\nfor clinic research on CAA and identification of early or presymptomatic\nCAA.</p>", "clean_text": "Conclusion\n\nThe results of our preliminary study suggest that a 99mTc(CO)3-labeled benzothiazole derivative, [99mTc]24, exhibited sufficient affinity for A\u03b2 aggregates and could selectively label A\u03b2 deposits in blood vessels of AD brain sections. The specific binding of [99mTc]24 and its selectivity to A\u03b2 deposits in blood vessel walls were validated by ex vivo autoradiographic experiments with Tg mice. Further experimental data will be required to confirm the utility of [99mTc]24 as novel imaging agent for clinic research on CAA and identification of early or presymptomatic CAA.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 38, "type": "text", "classification": ["else"], "content": "<p>In vitro and in vivo evaluations\nincluding eight figures and three tables as described in the text,\nas well as spectrograms for all synthesized complexes. The Supporting\nInformation is available free of charge on the <ext-link xlink:href=\"http://pubs.acs.org\" xlink:type=\"simple\">ACS Publications website</ext-link> at\nDOI: <ext-link xlink:href=\"http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.5b00209\" xlink:type=\"simple\">10.1021/acs.molpharmaceut.5b00209</ext-link>.</p>", "clean_text": "In vitro and in vivo evaluations including eight figures and three tables as described in the text, as well as spectrograms for all synthesized complexes. The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.molpharmaceut.5b00209.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 39, "type": "text", "classification": ["else"], "content": "<p>The authors\ndeclare no competing financial interest.</p>", "clean_text": "The authors declare no competing financial interest.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": "6, 7", "type": "text", "classification": "synthesis condition", "content": "<title>Synthesis</title><title>Synthesis of Compounds <bold>1</bold>\u2013<bold>8</bold>\n</title><p>A mixture of 2-(4-(methylamino)\u00adphenyl)\u00adbenzo\u00ad[<italic toggle=\"yes\">d</italic>]\u00adthiazol-6-ol\n(256.9 mg, 1.0 mmol) and K<sub>2</sub>CO<sub>3</sub> (429.9 mg, 3.1\nmmol) in CH<sub>3</sub>CN (30 mL) was stirred at 90 \u00b0C. After\n2 h, 1,3-dibromopropane (404.6 mg, 4.0 mmol) was added and the reaction\nmixture was kept at 90 \u00b0C for an additional 2 h. Then, K<sub>2</sub>CO<sub>3</sub> was filtered and CH<sub>3</sub>CN was removed\nunder vacuum. The residue was suspended in petroleum, and the product\nwas precipitated and filtered without further purification. Compounds <bold>2</bold>\u2013<bold>8</bold> were obtained by the same method as\ndescribed above. The yields and <sup>1</sup>H NMR data are shown in\nthe .</p><title>Synthesis\nof Compounds <bold>9</bold>\u2013<bold>16</bold>\n</title><p>A mixture\nof diethyl iminodiacetate (178.2 mg, 0.98 mmol), <bold>1</bold> (247.3\nmg, 0.65 mmol), K<sub>2</sub>CO<sub>3</sub> (268.7\nmg, 1.95 mmol), and KI (107.7 mg, 0.65 mmol) in CH<sub>3</sub>CN (10\nmL) was heated to reflux for 48 h at 90 \u00b0C. After CH<sub>3</sub>CN was removed, water was added, the resulting mixture was extracted\nby dichloromethane (3 \u00d7 20 mL), and the organic layer was dried\nover anhydrous MgSO<sub>4</sub>. The organic solvent was removed under\nvacuum, and the residue was purified by silica gel column chromatography\n(petroleum ether/AcOEt, 2/1) to yield 79.7 mg of <bold>9</bold> as\na light yellow solid. Compounds <bold>10</bold>\u2013<bold>16</bold> were obtained by the same method as described above. The yields\nand <sup>1</sup>H NMR and MS data are shown in the .</p>", "clean_text": "Synthesis\n\nSynthesis of Compounds 1-8 \n\nA mixture of 2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol (256.9 mg, 1.0 mmol) and K2CO3 (429.9 mg, 3.1 mmol) in CH3CN (30 mL) was stirred at 90 \u00b0C. After 2 h, 1,3-dibromopropane (404.6 mg, 4.0 mmol) was added and the reaction mixture was kept at 90 \u00b0C for an additional 2 h. Then, K2CO3 was filtered and CH3CN was removed under vacuum. The residue was suspended in petroleum, and the product was precipitated and filtered without further purification. Compounds 2-8 were obtained by the same method as described above. The yields and 1H NMR data are shown in the .\n\nSynthesis of Compounds 9-16 \n\nA mixture of diethyl iminodiacetate (178.2 mg, 0.98 mmol), 1 (247.3 mg, 0.65 mmol), K2CO3 (268.7 mg, 1.95 mmol), and KI (107.7 mg, 0.65 mmol) in CH3CN (10 mL) was heated to reflux for 48 h at 90 \u00b0C. After CH3CN was removed, water was added, the resulting mixture was extracted by dichloromethane (3 \u00d7 20 mL), and the organic layer was dried over anhydrous MgSO4. The organic solvent was removed under vacuum, and the residue was purified by silica gel column chromatography (petroleum ether/AcOEt, 2/1) to yield 79.7 mg of 9 as a light yellow solid. Compounds 10-16 were obtained by the same method as described above. The yields and 1H NMR and MS data are shown in the .", "data": [[{"meta": {"name": "Compounds 1-8", "symbol": "1-8", "chemical formula": ""}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol", "amount": "256.9", "unit": "mg"}, {"name": "K2CO3", "amount": "429.9", "unit": "mg"}, {"name": "1,3-dibromopropane", "amount": "404.6", "unit": "mg"}], "solution": [{"name": "CH3CN", "amount": "30", "unit": "mL"}], "pressure": "", "temperature": "90\u00b0C", "time": "4 hours"}, {"synthesis method": "filtration", "time": "", "atmosphere": "", "pressure": ""}], "yield": ""}, {"meta": {"name": "Compounds 9-16", "symbol": "9-16", "chemical formula": ""}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "diethyl iminodiacetate", "amount": "178.2", "unit": "mg"}, {"name": "1", "amount": "247.3", "unit": "mg"}, {"name": "K2CO3", "amount": "268.7", "unit": "mg"}, {"name": "KI", "amount": "107.7", "unit": "mg"}], "solution": [{"name": "CH3CN", "amount": "10", "unit": "mL"}], "pressure": "", "temperature": "90\u00b0C", "time": "48 hours"}, {"synthesis method": "filtration", "time": "", "atmosphere": "", "pressure": ""}], "yield": ""}]], "include_properties": ["chemical_synthesis", "filtration"], "intermediate_step": {"text-synthesis-type": "['chemical_synthesis', 'filtration']", "text-synthesis-struct": "```JSON\n[{\"meta\":{\"name\":\"Compounds 1-8\", \"symbol\":\"1-8\", \"chemical formula\":\"\"}, \"processes\":[{\"synthesis method\": \"chemical synthesis\", \"precursor\":[{\"name\":\"2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol\", \"amount\":\"256.9\", \"unit\":\"mg\"}, {\"name\":\"K2CO3\", \"amount\":\"429.9\", \"unit\":\"mg\"}, {\"name\":\"1,3-dibromopropane\", \"amount\":\"404.6\", \"unit\":\"mg\"}], \"solution\":[{\"name\":\"CH3CN\", \"amount\":\"30\", \"unit\":\"mL\"}], \"pressure\": \"\", \"temperature\": \"90\u00b0C\", \"time\": \"4 hours\"}, {\"synthesis method\": \"filtration\", \"time\": \"\", \"atmosphere\": \"\", \"pressure\": \"\"}], \"yield\": \"\"}, {\"meta\":{\"name\":\"Compounds 9-16\", \"symbol\":\"9-16\", \"chemical formula\":\"\"}, \"processes\":[{\"synthesis method\": \"chemical synthesis\", \"precursor\":[{\"name\":\"diethyl iminodiacetate\", \"amount\":\"178.2\", \"unit\":\"mg\"}, {\"name\":\"1\", \"amount\":\"247.3\", \"unit\":\"mg\"}, {\"name\":\"K2CO3\", \"amount\":\"268.7\", \"unit\":\"mg\"}, {\"name\":\"KI\", \"amount\":\"107.7\", \"unit\":\"mg\"}], \"solution\":[{\"name\":\"CH3CN\", \"amount\":\"10\", \"unit\":\"mL\"}], \"pressure\": \"\", \"temperature\": \"90\u00b0C\", \"time\": \"48 hours\"}, {\"synthesis method\": \"filtration\", \"time\": \"\", \"atmosphere\": \"\", \"pressure\": \"\"}], \"yield\": \"\"}]\n```"}}, {"idx": 31, "type": "text", "classification": "property", "content": "<title>Biodistribution Studies</title><p>The time\u2013radioactivity\ndata on brain penetration and the distribution of [<sup>99m</sup>Tc]<bold>24</bold> in other organs are displayed in Table . The results show a relatively low brain uptake of 1.21 \u00b1\n0.22% ID/g at 2 min postinjection and rapid blood washout with an\napproximately 23-fold decline in blood radioactivity at 60 min postinjection.\nOther complexes, [<sup>99m</sup>Tc]<bold>21</bold>, [<sup>99m</sup>Tc]<bold>22</bold>, and [<sup>99m</sup>Tc]<bold>23</bold> showed\nlower brain uptake (0.80 \u00b1 0.17, 0.61 \u00b1 0.08, and 0.88 \u00b1\n0.14% ID/g, respectively, in Table S3 in the ). These tracers are similar to most imaging agents\nin that they are metabolized by the liver and intestine. [<sup>99m</sup>Tc]<bold>24</bold> also exhibits remarkable stability in vitro and\nin vivo. As shown in Figure S8 in the , [<sup>99m</sup>Tc]<bold>24</bold> exists in the\nblood almost completely in its parent form after 30 min postinjection,\nand more than 50% is present in the urine at that time.</p>", "clean_text": "Biodistribution Studies\n\nThe time-radioactivity data on brain penetration and the distribution of [99mTc]24 in other organs are displayed in Table . The results show a relatively low brain uptake of 1.21 \u00b1 0.22% ID/g at 2 min postinjection and rapid blood washout with an approximately 23-fold decline in blood radioactivity at 60 min postinjection. Other complexes, [99mTc]21, [99mTc]22, and [99mTc]23 showed lower brain uptake (0.80 \u00b1 0.17, 0.61 \u00b1 0.08, and 0.88 \u00b1 0.14% ID/g, respectively, in Table S3 in the ). These tracers are similar to most imaging agents in that they are metabolized by the liver and intestine. [99mTc]24 also exhibits remarkable stability in vitro and in vivo. As shown in Figure S8 in the , [99mTc]24 exists in the blood almost completely in its parent form after 30 min postinjection, and more than 50% is present in the urine at that time.", "data": [[[{"property name": "brain uptake", "value": "1.21", "unit": "% ID/g", "condition": "2 min postinjection"}, {"property name": "blood washout", "value": "23", "unit": "fold decline", "condition": "60 min postinjection"}, {"property name": "stability", "value": "remarkable", "unit": "", "condition": "in vitro and in vivo"}, {"property name": "presence in blood", "value": "almost completely", "unit": "", "condition": "30 min postinjection"}, {"property name": "presence in urine", "value": "more than 50%", "unit": "", "condition": "30 min postinjection"}]]], "include_properties": ["etc"], "intermediate_step": {"categorize": "['property']", "text-property-type": "['etc']", "text-property-extract": "```JSON\n[\n    {\n        \"property name\": \"brain uptake\",\n        \"value\": \"1.21\",\n        \"unit\": \"% ID/g\",\n        \"condition\": \"2 min postinjection\"\n    },\n    {\n        \"property name\": \"blood washout\",\n        \"value\": \"23\",\n        \"unit\": \"fold decline\",\n        \"condition\": \"60 min postinjection\"\n    },\n    {\n        \"property name\": \"stability\",\n        \"value\": \"remarkable\",\n        \"unit\": \"\",\n        \"condition\": \"in vitro and in vivo\"\n    },\n    {\n        \"property name\": \"presence in blood\",\n        \"value\": \"almost completely\",\n        \"unit\": \"\",\n        \"condition\": \"30 min postinjection\"\n    },\n    {\n        \"property name\": \"presence in urine\",\n        \"value\": \"more than 50%\",\n        \"unit\": \"\",\n        \"condition\": \"30 min postinjection\"\n    }\n]\n```"}}, {"idx": 25, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Inhibition Constants (<italic toggle=\"yes\">K</italic>\n<sub>i</sub>, nM) for Binding to Aggregates of A\u03b2<sub>1\u201342</sub>\n<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">compound</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">K</italic>\n<sub>i</sub>\n</oasis:entry>\n<oasis:entry align=\"center\">compound</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">K</italic>\n<sub>i</sub>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>17</bold>\n</oasis:entry>\n<oasis:entry>106.0\u00a0\u00b1\u00a029.9</oasis:entry>\n<oasis:entry>\n<bold>21</bold>\n</oasis:entry>\n<oasis:entry>85.1\u00a0\u00b1\u00a011.2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>18</bold>\n</oasis:entry>\n<oasis:entry>45.3\u00a0\u00b1\u00a011.8</oasis:entry>\n<oasis:entry>\n<bold>22</bold>\n</oasis:entry>\n<oasis:entry>50.8\u00a0\u00b1\u00a012.5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>19</bold>\n</oasis:entry>\n<oasis:entry>46.0\u00a0\u00b1\u00a012.0</oasis:entry>\n<oasis:entry>\n<bold>23</bold>\n</oasis:entry>\n<oasis:entry>56.6\u00a0\u00b1\u00a04.1</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>20</bold>\n</oasis:entry>\n<oasis:entry>61.9\u00a0\u00b1\u00a08.4</oasis:entry>\n<oasis:entry>\n<bold>24</bold>\n</oasis:entry>\n<oasis:entry>42.2\u00a0\u00b1\u00a011.3</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>Measured in triplicate,\nwith results\nreported as the mean \u00b1 SD.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 1. Inhibition Constants (Ki, nM) for Binding to Aggregates of A\u03b21\u201342[^a]\n\n| compound | Ki | compound | Ki |\n|----------|----|----------|----|\n| 17       | 106.0 \u00b1 29.9 | 21       | 85.1 \u00b1 11.2 |\n| 18       | 45.3 \u00b1 11.8 | 22       | 50.8 \u00b1 12.5 |\n| 19       | 46.0 \u00b1 12.0 | 23       | 56.6 \u00b1 4.1 |\n| 20       | 61.9 \u00b1 8.4 | 24       | 42.2 \u00b1 11.3 |\n\n[^a]: Measured in triplicate, with results reported as the mean \u00b1 SD.", "data": [[{"meta": {"name": "17", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ki", "value": "106.0 \u00b1 29.9", "unit": "nM", "condition": "Measured in triplicate, with results reported as the mean \u00b1 SD."}]}, {"meta": {"name": "18", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ki", "value": "45.3 \u00b1 11.8", "unit": "nM", "condition": "Measured in triplicate, with results reported as the mean \u00b1 SD."}]}, {"meta": {"name": "19", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ki", "value": "46.0 \u00b1 12.0", "unit": "nM", "condition": "Measured in triplicate, with results reported as the mean \u00b1 SD."}]}, {"meta": {"name": "20", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ki", "value": "61.9 \u00b1 8.4", "unit": "nM", "condition": "Measured in triplicate, with results reported as the mean \u00b1 SD."}]}, {"meta": {"name": "21", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ki", "value": "85.1 \u00b1 11.2", "unit": "nM", "condition": "Measured in triplicate, with results reported as the mean \u00b1 SD."}]}, {"meta": {"name": "22", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ki", "value": "50.8 \u00b1 12.5", "unit": "nM", "condition": "Measured in triplicate, with results reported as the mean \u00b1 SD."}]}, {"meta": {"name": "23", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ki", "value": "56.6 \u00b1 4.1", "unit": "nM", "condition": "Measured in triplicate, with results reported as the mean \u00b1 SD."}]}, {"meta": {"name": "24", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ki", "value": "42.2 \u00b1 11.3", "unit": "nM", "condition": "Measured in triplicate, with results reported as the mean \u00b1 SD."}]}]], "include_properties": ["etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 1. Inhibition Constants (Ki, nM) for Binding to Aggregates of A\u03b21\u201342[^a]\n\n| compound | Ki | compound | Ki |\n|----------|----|----------|----|\n| 17       | 106.0 \u00b1 29.9 | 21       | 85.1 \u00b1 11.2 |\n| 18       | 45.3 \u00b1 11.8 | 22       | 50.8 \u00b1 12.5 |\n| 19       | 46.0 \u00b1 12.0 | 23       | 56.6 \u00b1 4.1 |\n| 20       | 61.9 \u00b1 8.4 | 24       | 42.2 \u00b1 11.3 |\n\n[^a]: Measured in triplicate, with results reported as the mean \u00b1 SD.\n<END>", "table-categorize": "Property", "table-property-type": "['etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"17\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ki\",\n                \"value\": \"106.0 \u00b1 29.9\",\n                \"unit\": \"nM\",\n                \"condition\": \"Measured in triplicate, with results reported as the mean \u00b1 SD.\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"18\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ki\",\n                \"value\": \"45.3 \u00b1 11.8\",\n                \"unit\": \"nM\",\n                \"condition\": \"Measured in triplicate, with results reported as the mean \u00b1 SD.\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"19\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ki\",\n                \"value\": \"46.0 \u00b1 12.0\",\n                \"unit\": \"nM\",\n                \"condition\": \"Measured in triplicate, with results reported as the mean \u00b1 SD.\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"20\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ki\",\n                \"value\": \"61.9 \u00b1 8.4\",\n                \"unit\": \"nM\",\n                \"condition\": \"Measured in triplicate, with results reported as the mean \u00b1 SD.\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"21\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ki\",\n                \"value\": \"85.1 \u00b1 11.2\",\n                \"unit\": \"nM\",\n                \"condition\": \"Measured in triplicate, with results reported as the mean \u00b1 SD.\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"22\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ki\",\n                \"value\": \"50.8 \u00b1 12.5\",\n                \"unit\": \"nM\",\n                \"condition\": \"Measured in triplicate, with results reported as the mean \u00b1 SD.\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"23\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ki\",\n                \"value\": \"56.6 \u00b1 4.1\",\n                \"unit\": \"nM\",\n                \"condition\": \"Measured in triplicate, with results reported as the mean \u00b1 SD.\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"24\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ki\",\n                \"value\": \"42.2 \u00b1 11.3\",\n                \"unit\": \"nM\",\n                \"condition\": \"Measured in triplicate, with results reported as the mean \u00b1 SD.\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 32, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Biodistribution in Normal Mice (ICR,\n5 Weeks, Male) after Iv Injection of [<sup>99m</sup>Tc]<bold>24</bold>\n<xref ref-type=\"table-fn\" rid=\"t2fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">organ</oasis:entry>\n<oasis:entry align=\"center\">2 min</oasis:entry>\n<oasis:entry align=\"center\">10 min</oasis:entry>\n<oasis:entry align=\"center\">30 min</oasis:entry>\n<oasis:entry align=\"center\">60 min</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>blood</oasis:entry>\n<oasis:entry>31.86\u00a0\u00b1\u00a03.19</oasis:entry>\n<oasis:entry>5.98\u00a0\u00b1\u00a00.78</oasis:entry>\n<oasis:entry>1.79\u00a0\u00b1\u00a00.24</oasis:entry>\n<oasis:entry>1.37\u00a0\u00b1\u00a00.14</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>brain</oasis:entry>\n<oasis:entry>1.21\u00a0\u00b1\u00a00.22</oasis:entry>\n<oasis:entry>0.19\u00a0\u00b1\u00a00.04</oasis:entry>\n<oasis:entry>0.07\u00a0\u00b1\u00a00.02</oasis:entry>\n<oasis:entry>0.06\u00a0\u00b1\u00a00.01</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>heart</oasis:entry>\n<oasis:entry>6.53\u00a0\u00b1\u00a00.79</oasis:entry>\n<oasis:entry>1.72\u00a0\u00b1\u00a00.15</oasis:entry>\n<oasis:entry>0.62\u00a0\u00b1\u00a00.07</oasis:entry>\n<oasis:entry>0.57\u00a0\u00b1\u00a00.14</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>liver</oasis:entry>\n<oasis:entry>25.64\u00a0\u00b1\u00a02.31</oasis:entry>\n<oasis:entry>34.65\u00a0\u00b1\u00a03.34</oasis:entry>\n<oasis:entry>21.79\u00a0\u00b1\u00a01.45</oasis:entry>\n<oasis:entry>11.01\u00a0\u00b1\u00a00.58</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>spleen</oasis:entry>\n<oasis:entry>3.36\u00a0\u00b1\u00a00.39</oasis:entry>\n<oasis:entry>1.06\u00a0\u00b1\u00a00.17</oasis:entry>\n<oasis:entry>0.49\u00a0\u00b1\u00a00.11</oasis:entry>\n<oasis:entry>0.38\u00a0\u00b1\u00a00.08</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>lung</oasis:entry>\n<oasis:entry>16.89\u00a0\u00b1\u00a02.13</oasis:entry>\n<oasis:entry>3.84\u00a0\u00b1\u00a00.73</oasis:entry>\n<oasis:entry>1.53\u00a0\u00b1\u00a00.08</oasis:entry>\n<oasis:entry>1.42\u00a0\u00b1\u00a00.22</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>kidney</oasis:entry>\n<oasis:entry>7.79\u00a0\u00b1\u00a00.84</oasis:entry>\n<oasis:entry>3.04\u00a0\u00b1\u00a00.53</oasis:entry>\n<oasis:entry>1.68\u00a0\u00b1\u00a00.20</oasis:entry>\n<oasis:entry>1.45\u00a0\u00b1\u00a00.15</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>pancreas</oasis:entry>\n<oasis:entry>1.63\u00a0\u00b1\u00a00.22</oasis:entry>\n<oasis:entry>1.20\u00a0\u00b1\u00a00.56</oasis:entry>\n<oasis:entry>0.55\u00a0\u00b1\u00a00.13</oasis:entry>\n<oasis:entry>0.34\u00a0\u00b1\u00a00.67</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>muscle</oasis:entry>\n<oasis:entry>0.77\u00a0\u00b1\u00a00.19</oasis:entry>\n<oasis:entry>0.76\u00a0\u00b1\u00a00.63</oasis:entry>\n<oasis:entry>0.26\u00a0\u00b1\u00a00.10</oasis:entry>\n<oasis:entry>0.28\u00a0\u00b1\u00a00.10</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>stomach<xref ref-type=\"table-fn\" rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry>0.77\u00a0\u00b1\u00a00.19</oasis:entry>\n<oasis:entry>0.76\u00a0\u00b1\u00a00.63</oasis:entry>\n<oasis:entry>0.26\u00a0\u00b1\u00a00.10</oasis:entry>\n<oasis:entry>0.28\u00a0\u00b1\u00a00.10</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>intestine<xref ref-type=\"table-fn\" rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry>1.67\u00a0\u00b1\u00a00.43</oasis:entry>\n<oasis:entry>13.65\u00a0\u00b1\u00a01.20</oasis:entry>\n<oasis:entry>47.57\u00a0\u00b1\u00a08.05</oasis:entry>\n<oasis:entry>28.34\u00a0\u00b1\u00a03.78</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>Expressed as %\ninjected dose per\ngram. Average for 5 mice \u00b1 SD.</p>\n</fn>\n<fn id=\"t2fn2\">\n<label>b</label>\n<p>Expressed as % injected dose per\norgan.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 2. Biodistribution in Normal Mice (ICR, 5 Weeks, Male) after Iv Injection of [99mTc]24[^a][^b]\n\n| organ    | 2 min       | 10 min      | 30 min      | 60 min      |\n|----------|-------------|-------------|-------------|-------------|\n| blood    | 31.86 \u00b1 3.19 | 5.98 \u00b1 0.78  | 1.79 \u00b1 0.24  | 1.37 \u00b1 0.14  |\n| brain    | 1.21 \u00b1 0.22 | 0.19 \u00b1 0.04 | 0.07 \u00b1 0.02 | 0.06 \u00b1 0.01 |\n| heart    | 6.53 \u00b1 0.79 | 1.72 \u00b1 0.15 | 0.62 \u00b1 0.07 | 0.57 \u00b1 0.14 |\n| liver    | 25.64 \u00b1 2.31 | 34.65 \u00b1 3.34 | 21.79 \u00b1 1.45 | 11.01 \u00b1 0.58 |\n| spleen   | 3.36 \u00b1 0.39 | 1.06 \u00b1 0.17 | 0.49 \u00b1 0.11 | 0.38 \u00b1 0.08 |\n| lung     | 16.89 \u00b1 2.13 | 3.84 \u00b1 0.73 | 1.53 \u00b1 0.08 | 1.42 \u00b1 0.22 |\n| kidney   | 7.79 \u00b1 0.84 | 3.04 \u00b1 0.53 | 1.68 \u00b1 0.20 | 1.45 \u00b1 0.15 |\n| pancreas | 1.63 \u00b1 0.22 | 1.20 \u00b1 0.56 | 0.55 \u00b1 0.13 | 0.34 \u00b1 0.67 |\n| muscle   | 0.77 \u00b1 0.19 | 0.76 \u00b1 0.63 | 0.26 \u00b1 0.10 | 0.28 \u00b1 0.10 |\n| stomach[^2] | 0.77 \u00b1 0.19 | 0.76 \u00b1 0.63 | 0.26 \u00b1 0.10 | 0.28 \u00b1 0.10 |\n| intestine[^2] | 1.67 \u00b1 0.43 | 13.65 \u00b1 1.20 | 47.57 \u00b1 8.05 | 28.34 \u00b1 3.78 |\n\n[^a]: Expressed as % injected dose per gram. Average for 5 mice \u00b1 SD.\n[^b]: Expressed as % injected dose per organ.", "data": [[{"meta": {"name": "blood", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Biodistribution", "value": "31.86 \u00b1 3.19", "unit": "% injected dose per gram", "condition": "2 min"}, {"property name": "Biodistribution", "value": "5.98 \u00b1 0.78", "unit": "% injected dose per gram", "condition": "10 min"}, {"property name": "Biodistribution", "value": "1.79 \u00b1 0.24", "unit": "% injected dose per gram", "condition": "30 min"}, {"property name": "Biodistribution", "value": "1.37 \u00b1 0.14", "unit": "% injected dose per gram", "condition": "60 min"}]}, {"meta": {"name": "brain", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Biodistribution", "value": "1.21 \u00b1 0.22", "unit": "% injected dose per gram", "condition": "2 min"}, {"property name": "Biodistribution", "value": "0.19 \u00b1 0.04", "unit": "% injected dose per gram", "condition": "10 min"}, {"property name": "Biodistribution", "value": "0.07 \u00b1 0.02", "unit": "% injected dose per gram", "condition": "30 min"}, {"property name": "Biodistribution", "value": "0.06 \u00b1 0.01", "unit": "% injected dose per gram", "condition": "60 min"}]}, 